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1. Summary: 
 
Inflammation is a beneficial response of the organism to harmful stimuli, but it can have 
detrimental effects if not resolved in time or occurs exaggerated. Chronic inflammatory 
conditions play a role in the pathogenesis of various severe diseases. Thus, mechanisms 
that cause shutting down of inflammation are important targets of studies. Endothelial cells 
lining the vasculature are actively contributing to inflammatory reactions. Upon pro-
inflammatory stimulation they undergo phenotypic changes that enable the passage of 
immune cells through the endothelium to the side of injury. On the molecular level these 
processes are mainly regulated by inducible transcription factors like NF-κB, AP-1 and 
NFAT. Amongst their target genes are not only pro-inflammatory genes, but also genes 
encoding proteins that cause the resolution of the reaction at later stages. These gene 
products represent “negative feedback loops”. For the identification of novel negative 
feedback loops, some genes were selected that were found previously to be inducible in 
human vascular endothelial cells (HUVEC) by the pro-inflammatory cytokine IL-1, and are 
supposed to have repressive potential. These genes of interest were cloned into mammalian 
expression vectors and used to perform different reporter gene assays.  
One of the examined genes, GG2-1, encodes a member of the FLICE-inhibitory family of 
anti-apoptotic proteins that possesses oncogenic potential. In AP-1 and NF-κB reporter gene 
assays, the protein exhibited significant inhibitory effects on the transcription factors when 
their activation was achieved by co-transfection of MEKK1. Accordingly, the activity of the IL-
8 promoter was suppressed by GG2-1. Western blotting revealed that the decrease of 
MEKK1 on the protein level correlated with increasing concentrations of GG2-1. This effect 
seemed to be specific for MEKK1, since protein levels of other MAP3K were not influenced 
by GG2-1 overexpression. Co-immunoprecipitation excluded direct protein interaction 
between the two proteins.  
Another target of studies was JAG1 that encodes one of the ligands of Notch1, Jagged-1. 
Notch signalling is involved in cell-cell communication and developmental processes. 
Mutations of JAG1 cause the Alagille syndrom (AGS), an autosomal dominant disorder 
affecting various systems of the body. In endothelial cells Jagged-1 plays a role in contact-
inhibition by regulating the Retinoblastoma (Rb) protein, in other cell types Jagged-1 exhibits 
oncogenic properties. In reporter gene assays examining pro-inflammatory transcription 
factors, Jagged-1 did not show considerable inhibitory effects, whereas the activity of the 
tumor-suppressor p53 was significantly suppressed.
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2. Introduction 
 
2.1. Inflammation as a beneficial response 
 
Inflammation is a complex response of the organism to harmful stimuli like toxic, infectious, 
traumatic or autoimmune injury. [1] In the course of an inflammatory reaction these stimuli 
are removed and the healing process is initiated. At best the original structure and tissue 
function is reconstituted. If the injury is too extensive and the initial state can not be 
recreated, structural integrity is provided by mechanisms like scarring, fibrosis or sclerosis. 
[2]  
A classical acute inflammation manifests itself with the symptoms rubor, dolor, calor, tumor 
and laesa (redness, pain, heat, swelling, loss/disturbance of function). [1] Most of these 
symptoms are caused by changes in the vasculature. In the surrounding of the injury small 
blood vessels widen and thereby cause a local increase of blood supply. As a consequence, 
the tissue shows redness and development of heat. Simultaneously, the blood vessels 
enhance their permeability and fluid containing immune cells accumulates in the surrounding 
tissue which leads to swelling. [3] The pains that typically go along with an inflammation are 
caused by mediators that act on C-type sensory nerve fibers. [4] All these symptoms are 
reversible, only the loss or disturbance of function can persist if the severity of the injury 
necessitates replacement of the original structures by fibrotic material. [2]  
An inflammation is based on the interplay of many different cells types. Communication 
between theses cells is mainly mediated by inflammatory mediators, including chemokines, 
cytokines and lipid mediators. These are soluble molecules that bind to specific receptors on 
inflammatory cells and thereby stimulate their targets.  
The first step of an inflammatory reaction is the detection of the injury. Not only cells of innate 
immunity, but also most somatic cells can sense the presence of intruders or damages of the 
tissue. In response they initiate an inflammatory reaction by liberation of pro-inflammatory 
signal transducers. [2] The formerly mentioned vasodilation and vascular permeability is 
caused by histamines and prostagladins. These molecules are released from the granulae of 
mast cells located in peripheral tissues and circulating basophiles in response to injury. As 
consequence, phagocytes recruited by chemotactical signals can accumulate in the tissue. 
[3] The first immune cells arriving in the lesion are neutrophiles. They carry various receptors 
for sensing stress signals sent by somatic cells and pathogen-associated molecules. 
Additionally they express adhesion molecules for interactions with activated endothelial cells. 
Introduction 
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These properties allow them to invade the side of injury very fast and remove bacteria and 
particles by phagocytosis. [5] Second, monocytes accumulate. Monocytes are long living 
cells. During the course of the inflammatory reaction they differentiate into macrophages and 
dentritic cells. The former ones do not only remove invaders and cell debris, but also 
apoptotic inflammatory cells, like the short-lived neutrophiles. Dendritic cells are professional 
“antigen-presenting” cells. Upon uptake and processing of antigenic material they migrate 
from the side of injury and activate T cells. By this process, activation of the adaptive immune 
system is induced and provides antigen-specific reactions and immunological memory 
mediated by T- and B-lymphocytes [5].  
In summary, inflammation plays an essential role in the maintenance of tissue homeostasis 
by restoration of original tissue structure and function. It is an important defense mechanism 
against infections and induces both, innate and adaptive immune response [2]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.1.: Inflammation and its effects 
              Graphic: “Dampening  
              Inflammation” [2] 
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2.2. Termination of inflammatory reactions 
 
As described in the previous chapter, inflammation is originally an advantageous reaction of 
the organism. However, if it occurs exaggerated or is not terminated in time, it can have 
detrimental effects on the organism.[1,6] Chronic inflammation is a factor in the pathogenesis 
of diseases like cancer, asthma, Alzheimer, Crohn´s disease, multiple sclerosis, 
artheriosclerosis, rheumatoid arthritis, juvenile diabetes, eczema, and psoriasis. [1, 6-10]  For 
this reason the resolution of the inflammatory reaction is an important topic of studies. There 
are mainly three prerequisites for the shutting down of the reaction:  
1) An essential factor is the complete elimination of the harmful stimulus. Chronic 
inflammations are often caused the continuous confrontation with the initial trigger. Thus, 
autoimmune reactions that are caused by recognition of the tissue itself are predestinated to 
cause persistent inflammations. [2]  
2) To avoid the chemoattraction of new inflammatory cells to the side of injury, a switch has 
to occur from pro-inflammatory to anti-inflammatoy mediators. Whereas in the initial phase 
prostaglandines and leukotrienes are produced, in the resolution phase lipoxines, resolvins 
and protectins are enriched.[1,11]  This switch is, amongst others, achieved by changes in 
signalling pathways that initially lead to transcription of genes encoding enzymes that direct 
the synthesis of pro-inflammatory mediators belonging to the eicosanoids (e.g. E2, D2). In the 
course of the inflammatory reaction they induce the generation of enzymes that catalyze the 
synthesis of anti-inflammatory classes of these lipid mediators. The formerly mentioned 
lipoxines do not only actively prevent the invasion of new neutrophiles, but also mediate a 
decrease of the vascular permeability and stimulation of macrophages. Additionally, they 
seem to play an active role in the initiation of wound healing. [11] 
3) Last but not least, apoptotic immune cells and debris of somatic cells have to be removed 
from the lesion. Especially the short-lived neutrophiles must be elimiminated after they have 
undergone apotosis. The removal is achieved by “efferocytosis”, a phagoytic process 
performed mainly by macrophages, but also by dentritic and somatic cells.  As a side effect, 
the recognition of apoptotic cells leads to an increase of anti-apoptotic mediators and growth 
or maintenance factors for tissue cells (e.g. TGF-β). This helps to restore tissue structure and 
function. [2]  
The last step of an inflammatory reaction is the exit of surviving monocytes through the 
lymphatic system. [1] 
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2.3. Endothelial cells in inflammation: 
 
Endothelial cells represent the inner surface of blood as well as lymphatic vessels all over 
the circulatory system. This layer it builds an anticoagulant, nonadhesive barrier between the 
blood stream and the underlying tissue. [3]  
The endothelium contributes actively to inflammatory reactions. In response to pro-
inflammatory stimuli (IL-1, TNF-α, LPS) it undergoes changes in permeability, enables 
adhesion of leucocytes and develops thrombogenic properties. [6] The basis for these 
alterations is the induction of a complex gene expression program. Up-regulated genes 
include pro-inflammatory cytokines, chemokines, growth factors (e.g. IL-1, IL-6, IL-8, M-CSF, 
G-CSF, GM-CSF) and cell-adhesion molecules (E-selectin, VCAM-1, ICAM-1). [12]  
By chemoattraction, circulating leucocytes are recruited to the vascular wall. There they are 
“tethered” by low affinity bindings to selectins on the surface of activated EC. By forming and 
breaking these bindings the leucocytes “roll” along the vessel wall and become activated. 
This activation is supported by chemokines released by macrophages and causes a switch 
of the surface receptors from low to high affinity state. As consequence the rolling leucocytes 
are “arrested” on the endothelium and polarization occurs. Subsequently they can migrate 
through the venular wall by “diapedesis”. This process requires transient opening of 
endothelial cell junctions and degradation of the basement membrane. Alterations in the 
function of cell junction proteins and contractile forces in the EC are induced by interaction of 
up-regulated adhesion molecules (e.g. PECAM-1) with their ligands on the activated 
leucocytes. The penetration of the basement membrane is enabled by secretion of leucocytic 
proteases. After entering the interstitial fluid the leucocytes move to the side of injury guided 
by chemoattractants. [5] 
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Fig.2.2.:  
Tethering and Rolling of 
leucocytes on the surface of 
activated endothelium  
Fig. 2.3.: 
Arrest and diapedesis 
Both Graphics from the 
Homepage of “UCL Division of 
Medicine, Royal Free & 
University College Medical 
School, Centre for 
Rheumatology and connective 
Tissue Disease” 
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2.4. Regulation of Inflammation in Endothelial Cells 
 
In response to pro-inflammatory stimulation, endothelial cells change their phenotype. The 
molecular basis for these processes is a mostly a complex gene expression program that 
requires tightly controlled regulatory mechanisms. These seem to be provided mainly by 
transcriptional regulation mediated by different inducible transcription factors. [6]  
 
2.4.1. Activation of NF-κB  
 
NF-κB is probably the most prominent and best characterized example for a primary 
transcription factor. It is present in the cell in an inactive state, upon induction it gets 
activated. Thus, de novo synthesis is not necessary and the transcription factor is able to 
react very fast to stimulation of the cell.   
In humans there are five members of the NF-κB family: p50, p52, RelA, RelB and c-Rel. All 
of them carry a Rel homology domain (RHD) on their N-terminus. This 300 amino acid 
spanning domain enables the formation of homo- and heterodimers and binding to κB sides 
in the promoter and enhancer sequences of target genes. Via transcriptional activation 
domains (TADs) on their C-terminus RelA, RelB and c-Rel can activate the expression of 
target genes. p50 and p52 lack this domain and therefore act either as transcriptional 
repressors when forming homodimers, or as activators when heterodimerizing with proteins 
carrying a TAD. In contrast to the other members of the family, p50 and p52 are derived from 
precursors (p105, p100, respectively). [13] 
NF-κB is activated by two different signaling pathways. The canonical or classical pathway is 
initiated by pro-inflammatory inducers like TNFα, IL-1 or LPS. These ligands bind to their 
specific receptors (TNFRs, IL-1 receptor, TLRs) on the surface of the endothelial cell and 
thereby cause the recruitment of various cytoplasmatic adaptor molecules (e.g. RIP, TRAF-1, 
TRAF -2, TRAF-6, MyD88). The signals are transmitted to different mitogen activated protein 
(MAP) kinases (e.g. MEKK1, MEKK2, MEKK3, TAK1) that activate various signaling 
cascades and converge at the IKK signaling complex.  This consists of IKKα, IKKβ and a 
noncatalytic subunit (NEMO or IKKγ).  Upon activation, the IKKs phosphorylate the inhibitors 
of NF-κB (IκBα) on their serine residues e.g., 32 and 36 in IkBa. These specific 
phosphorylations enable ubiquitination of IκBα by an E3 ubiquitin ligase complex followed by 
proteasomal degradation via the 26S proteasome. As a consequence the complex between 
NF-κB and its inhibitors is dissociated, its nuclear localization signal is exposed and the 
transcription factor translocates to the nucleus where it directs the expression of its target 
Introduction 
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genes. [1,14] Among them are chemokines and cytokines (e.g. IL-1, IL-2, IL-6, IL-8, TNFα, 
TNFβ), adhesion molecules (VCAM-1, ICAM-1, E-selectin, P-selectin), growth factors (G-
CSF, M-CSF, GM-CSF) and stress response genes. [15] 
The alternative or non-canonical pathway is induced e.g. by activation of the lymphotoxin-β 
receptor or TNFR1 and results in the activation of NIK (NF-κB-inducing kinase). NIK 
phosphorylates and thereby activates an IKK complex consisting of two IKKα subunits. The 
complex phosphorylates the C-terminal domain of p100. Consequently p52/RelB is liberated 
and can translocate to the nucleus. 
$ 
 
2.4.2. Activation of AP-1  
  
Another important transcription factor contributing to inflammatory reactions is the activator 
protein 1. AP-1 is a heteromeric protein consisting of proteins that belong to the c-Jun, c-Fos, 
ATF and JDP families. Activation is caused by a variety of different stimuli like cytokines, 
growth factors and bacterial and viral infections. Its composition and target genes are 
dependent on the type of signal and the consequently activated signaling pathway. [16] 
Binding of ligands to TNF-R1 leads to recruitment of TRADD to the cytoplasmatic “death 
domain” of the receptor, followed by binding of RIP-1 and TRAF-2. As a consequence, the 
SAP kinase cascade is induced and leads to activation of JNK. This kinase phosphorylates 
c-Jun and thereby enables the formation of a heterodimer with e.g. c-Fos. Expression of c-
Fos is mainly achieved via the ERK pathway. In this composition AP-1 affects the expression 
Fig.2.4., (left): 
The canonical/classical pathway 
of NF-κB activation 
Various signalling pathways lead to 
activation of the IKK complex. As 
consequence, IκBα is 
phosphorylated, ubiquitinated and 
degraded. 
Fig.2.5., (right): 
The non-canonical/alternative 
pathway of NF-κB activation  
Upon receptor stimulation NIK is 
activated and phosphorylates the 
IKK complex consisting of two 
IKKα subunits. Consequently the 
IkB domain of p100 is 
phosphorylated and p52/RelB can 
translocate to the nucleus. 
Both graphics: Overview of NF-kB 
signalling; 
 www.abcam.com [13] 
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of genes required for inflammatory processes like cytokines, chemokines and adhesion 
molecules. In other variations AP-1 is involved in the control of various cellular processes 
including differentiation, proliferation and apoptosis. [17] 
 
 
 
2.4.3. Activation of NFAT  
 
Nuclear factor of activated T-cells (NFAT) is known to be required for the expression of pro-
inflammatory cytokines like IL-2, IL-4 and TNF-α. Usually it acts in association with other 
transcription factors, e.g. AP-1. In mammals the NFAT family consists of four members: 
NFAT1-NFAT4. NFAT is regulated by calcium signaling. In unstimulated cells, NFAT is 
present in an inactive, serine-phosphorylated state. In response to increasing calcium levels 
the calcium sensor protein calmodulin (CaM) activates the serin/threonine phosphatase 
calcineurin (CN) and thereby leads to dephosphorylation of NFAT. As consequence its 
nuclear localization signal is exposed, NFAT can translocate to the nucleus and modulate the 
expression of its target genes. [19]  
 
 
Fig.2.6.: 
Activation of AP-1 
In response to pro-inflammatory stimulation the 
ERK-pathway is activated and leads to 
expression of c-Fos. 
Induction of the SAPK cascade leads to 
activation of JNK. Consequently c-Jun is 
phosphorylated and is able form a heterodimer 
with c-Fos. 
Graphic from „Regulation der Stabilität der 
proangiogenen Transkriptionsfaktoren c-Jun, 
Id1 und Id3 durch das COP9-Signalosom“; [18] 
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2.4.4. Activation of CHOP 
 
CHOP is a member of the C/EBP (CCAAT/enhancer binding protein) family of transcription 
factors. It acts as central mediator of ER-stress induced apoptosis and is therefore activated 
by two signaling pathways involved in the UPR (unfolded protein response), the PERK and 
the ATF6 pathway. CHOP is also target of the p38 MAPK pathway, another signaling 
cascade induced by cellular stress like stimulation by cytokines, irradiation, heat or osmotic 
shock. Target genes of activated CHOP are pro-apoptotic factors like DR5, TRB3, BIM and 
GADD34. [20,21] The mechanism by which CHOP mediates apoptosis is not known, but 
because the ER-stress pathway stands in close context to the initiation of inflammatory 
reactions CHOP is a target of these studies.  
 
2.4.5. Activation of p53 
 
The transcription factor p53 plays an important role as tumor suppressor and “guardian of the 
genome” (Lane, 1992). It is massively involved in the regulation of the cell cycle and is able 
to avoid the amplification of damaged DNA. p53 is activated by stress signals including DNA 
damage by post-transcriptional modifications. Upon activation it induces growth arrest and 
the expression of a variety of genes involved e.g. in the DNA repair. If the damage is too 
extensive, p53 can send the cell into growth arrest or apoptosis.  
The regulation of p53 is very complex, several negative and positive feedback loops are 
known, and the pathway stands in close context to many other signaling pathways of the cell. 
[22] Also, some members of the MAP kinases (JNK, p38, ERK) are able to transmit stress 
Fig. 2.7.: 
Activation of NFAT 
In response to increasing calcium levels 
Calmodulin (CaM) activates calineurin (CN). 
Consequently NFAT is dephoshorylated and 
thereby activated. 
Graphic:www.angiobodies.com; “Universidad 
Autonoma de Madrid”
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signals to p53 by phosphorylation of its transcriptional activation domain. [23] The inducibility 
of p53 by MAP kinases involved in pro-inflammatory signaling and the observation that it can 
be inactivated by a pro-inflammatory cytokine (MIF) [24] makes it to a target of studies in the 
context of inflammation, although it is not directly involved in this reaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.8.: 
Function of p53 
In response to stress signals tp53 is 
activated and causes cell cycle 
arrest allowing DNA repair or 
apoptosis 
Graphic: „the tp53 webside“ 
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2.5. Negative Feedback Loops 
 
 
The termination of an inflammatory reaction occurs on various levels. On the level of gene 
expression it is partly achieved by “negative feedback loops”. This term describes the 
phenomenon, that pro-inflammatory stimuli do not only induce the expression of pro-
inflammatory genes, but also of those that cause the resolution of the reaction at later time 
points. Thus, the stage for termination of the reaction is set very early in the activation 
phase.[1] 
A prominent example for a “negative feedback loop” is the NF-κB-dependent synthesis of 
IκBα. Among a variety of other target genes, NF-κB induces also the expression of its 
inhibitor IκBα. The newly synthesized protein translocates to the nucleus where it targets NF-
κB for export to the cytoplasm and thereby inactivates it. [25, 26] 
Another NF-κB-inducible gene is A20. A20 inhibits the TNF-induced activation of NF-κB by 
two different functions. As mentioned above, an essential step in TNFR signaling is the 
recruitment of cytoplasmatic adaptor proteins to the activated receptor complex. One such 
adaptor is RIP1, which is ubiquitiniated by TRAF-2 and can consequently transmit the signal 
towards the IKK complex. A20 inhibits RIP-1 signalling in a process involving two steps: First, 
it removes activating Lys63-linked ubiquitin chains via its N-terminal OTU domain. Second, it 
attaches Lys48-linked ubiquitin chains by its C-terminal zinc finger (Ub ligase) domain. This 
ubiquitination targets RIP-1 for proteosomal degradation and thereby leads to the inhibition of 
TNF-R signalling. [27]  
 
 
 
 
Fig. 2.9.: 
Inhibition of TNFR signaling by  
dual activity of NF-κB induced A20 
(1) TRAF2 ubiquitinates and thereby 
activates RIP 
(2) A20 removes activating ubiquitin 
chains from RIP via its OUT domain 
(3) A20 attaches ubiquitin chaines at 
RIP via its zinc-finer domain 
(4) This ubiquitination targets RIP for 
proteosomal  degradation resulting in 
inhibition of TNFR signalling 
Graphic: “A20 inhibits NF-kB 
activation by dual ubiquitin editing 
function” [28] 
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2.6. Background of the project 
 
The foundations of the project were laid by a micro array experiment performed by Mayer, de 
Martin et al. [6] The aim of this experiment was to get an overview of the immediate-early to 
early gene expression in stimulated HUVECs.  
The cells were stimulated with the pro-inflammatory cytokine IL-1 for various periods of time 
(0.5h, 1h, 2.5h and 6h) or remained unstimulated as control. Expression profiles were 
analysed using Affimetrix U133 micro arrays. 137 genes were shown to be regulated more 
than four-fold, among these genes 18 were known to encode transcription factors. In order to 
identify novel negative regulatory mechanism of inflammation, genes were selected that were 
known or suspected to have repressive potential in a different context.  
 
  
Tab. 2.1.: Micro array experiment 
                IL-1 induced genes with inhibitory potential 
                Table from “Resolution of inflammation” [1] 
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During the “Vertiefungsübungen” the results of the micro array were verified for a number of 
selected genes using real time PCR. At first the original cDNA analyzed in the micro array 
was tested. I was largely able to confirm the expression patterns, also when the magnitude of 
expression was in some cases different from the results of the micro array. The four genes 
that showed the highest inducibility were chosen to be targets of further studies: GG2-1, 
JAG1, TNFRSF11B and TNFSF15.  
To substantiate the results for these genes, an independent source of mRNA was analyzed. 
HUVECs were stimulated with IL-1 for two different durations (2h, 4h) or remained 
unstimulated. Also in this approach the expression patterns could be reproduced by real time 
PCR (data not shown). 
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Fig.2.10.: Fold-induction of selected genes in response to IL-1 stimulation of HUVECs  
                Comparison micro array – real time PCR 
Introduction 
15 
 
2.7. GG2-1 
 
GG2-1 encodes a cytosolic protein of ~21kDa and is induced by TNF-α via activation of NF-
κB in various human cancer cells, rheumotoid arthritis synovial fibroblasts and vascular 
endothelial cells.[29] 
G22-1 was described the first time in a publication of Patel, Wang et al. in 1997. In order to 
identify genes involved in tumor progression and/or metastasis, they established cell lines of 
primary and metastatic human head and neck squamos cell carcinomas (HNSCC) from the 
same patient. The expression profiles were compared and beside six other genes, GG2-1 
was found to be differentially expressed. The fact that the expression level of GG2-1 was 
significantly higher in the metastatic cell line led to the suggestion that it encodes a protein 
involved in tumorigenesis. [30] 
Further studies using bioinformatical methods revealed that GG2-1 contains a death effector 
domain (DED) on its amino-terminal end. DEDs are important features of proteins involved in 
apoptosis. The death receptors TNFR1 and Fas carry a cytoplasmic domain that is bound by 
TRADD (TNFR-associated death domain). TRADD serves as adaptor molecule and can 
recruit FADD. Via death effector domains FADD interacts with caspase-8 resulting in the 
receptor-associated death inducing signaling complex (DISC). This is the beginning of a 
caspase cascade leading to apoptosis. Not in every cell type apoptosis is induced by TNFR1 
or Fas activation. In these cases the signaling pathway is inhibited by members of the FLICE 
inhibitory family of anti-apoptotic proteins (FLIP, CASH, I-FLICE, FLAME-1).  These proteins 
contain sequences with a significant homology to the death effector domains of TRADD and 
caspase-8, but no catalytic caspase domain. Via the death effector domain they can bind 
caspase-8 and thereby inhibit its capacity to activate down stream caspases by proteolytic 
cleavage.  
The presence of a DED and the observed ability of GG2-1 to inhibit TNF-induced apoptosis, 
led to the conclusion that GG2-1 belongs to this protein family. [31] This suggestion could be 
supported by the observation that GG2-1 inhibits the activity of caspase-8, whereby it is not 
known how it is acting on the signal pathway. In contrast to other members of its protein 
family (FLIP) it does not block the processing of caspase-8. Thus, it might act downstream 
from the DISC formation. 
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The oncogenic function of GG2-1 could be confirmed by various studies. Human breast 
cancer cell lines show enhanced DNA synthesis, proliferation and tumor growth rate when it 
is over-expressed. Additionally it is up-regulated in various human breast and renal 
carcinomas. In vivo experiments showed that GG2-1 over-expression in human breast 
cancer cells enhances their potential to perform pulmonary colonization. Vice versa, the 
inhibition of enogenous GG2-1 using antisense nucleotides causes decreased metastasis. 
Eventually these effects are caused by downregulation of VEGFR-2. This receptor tyrosine 
kinase is expressed in vascular endothelial cells and many types of tumor cells. As major 
receptor of VEGF-A it plays an essential role in endothelial cell proliferation and in autocrine 
and paracrine mechanisms of tumor growth and metastasis. It has been shown that reduced 
GG2-1 expression correlates with decreased VEGFR-2 expression, whereby VEGFR-1 and -
3 expression is not affected. Also members of another protein family known to be involved in 
metastasis are suppressed when GG2-1 is down-regulated. Matrix degrading 
metalloproteases (MMPs) act by degrading components of the ECM and thereby facilitate 
invasion and extravasion of tumor cells. The expression of MMP-1 and MMP-9 correlates 
with GG2-1 expression in human cancer cells, whereas MMP-2 expression does not. [29]  
GG2-1 seems also to act as inhibitor in another context. By performing a large-scale 
functional genetic screen for inhibitors of TCR signaling, GG2-1 was among the identified 
genes. The mechanism causing GG2-1 mediated TCR inhibition remains to be elucidated 
[33]. The function of GG2-1 in endothelial cells is unknown. 
Fig.2.11.: 
TNFR signaling pathway leading to 
apoptosis 
The activated TNFR recruits the adapter 
molecule TRADD which activates FADD. 
Interactions beween the death effector 
domains of procaspase-8 and FADD lead 
to the formation of the death inducing 
signaling complex (DISC). Activated 
caspase-8 initiates a caspase cascade 
leading to apoptosis. 
FLIP can prevents the processing of 
caspase-8 and thereby inhibit the signalling 
pathway. 
Modified Graphic: “How melanoma cells 
evade trail-induced apoptosis” [32]  
Introduction 
17 
 
2.8. JAG1 
 
JAG1 encodes the jagged 1 protein that functions as a ligand of Notch1. The Notch signaling 
pathway plays an important role in cell-cell communication and developmental processes.  
During embryogenesis it regulates cell fate decisions in tissues derived from all three primary 
germ layers. Thus, it is obvious that Notch signaling is involved in various independent 
processes. Among others it plays an important role in hematopoiesis and lymphocyte 
development, somitogenesis, neurogenesis and vasculogenesis.  
Four different Notch receptors (Notch1-4) are expressed in mammals. All of them are 
synthesized as single polypeptides, but upon cleavage and transport to the cell surface, they 
act as heterodimers. Notch receptors are membrane spanning molecules. In their 
extracellular domains they contain variable numbers of tandem EGF (epidermal growth 
factor)-like repeats that enable interactions with the respective ligands. Upon ligand binding 
their intracellular domain (NIC) is set free by proteolytic cleavage and translocates to the 
nucleus. There it binds CSL, a transcriptional regulator. In the absence of NIC CSL blocks 
gene expression by binding RTGGGAA elements and recruiting various co-repressors. 
Cleaved NIC replaces these inhibitory elements, recruits transcriptional co-activators and 
consequently induces expression of its target genes. Target genes are members of the HES 
(hairy/enhancer split) and HRT (hairy-related transcription factor) family of proteins. 
 
 
 
 
 
 
 
 
 
 
Fig. 2.12.:  
Gene expression induced by Notch signaling 
In unstimulated cells gene expression is inhibited by binding of the transcriptional regulator CSL and co-
repressors to specific elements. 
Upon activation of the Notch receptor its intracellular domain (N-IC) is released, translocates to the nuleus 
and interacts with CSL and co-activators leading to expression of target genes  
Graphic: “Notch signaling in development and disease” [34] 
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Five different ligands are known to exist in humans: Three delta-like ligands (Dll1-3), and two 
Serrate-like ligand (Jagged-1 and Jagged-2). All of them are transmembrane proteins 
possessing tandem EGF-like repeats and a single DSL-binding domain in their N-terminus 
for interactions with the Notch receptors.  
There are two different possibilities for the activation of the Notch signaling pathway: The 
term “inductive signaling” describes the interactions between two different cell types 
expressing either the receptor or the ligand. In this case only in the cell possessing the 
receptor the pathway is initiated. “Lateral signaling” occurs between two cells of the same 
type expressing both, the receptor and the ligand. As consequence Notch signaling is 
induced in both cells. [34]   
 
 
Mutations of JAG1 cause the Alagille syndrom (AGS). This autosomal dominant hereditary 
disease is a developmental disorder affecting various systems of the body. Symptoms are a 
reduced number of bile ducts and abnormalities concerning the heart, eyes, skeleton, face, 
kidneys, pancreas and vasculature. [36] 94% of patients suffering from AGS have been 
shown to carry mutations of JAG1, whereby these mutations are very versatile. They 
comprise total gene deletions, frameshifts, nonsense and missense mutations. [37] The fact 
that a small number of patients show deletions of the entire gene indicates that AGS is 
caused by haploinsufficiency. This suggestion is confirmed by the observation that these 
patients show a similar phenotype to patients carrying intragenic mutations. [36, 37]    
JAG1 expression has been proven to be essential for vascular remodeling. JAG1 knockout 
mice die between embryonic day 10.5 and 11.5 due to abnormalities in the yolk sac and 
vasculature. [38] 
Fig.2.13.: 
„Inductive“ Notch signaling 
Two different cell types interact via Notch 
receptor and ligand. 
Graphic: “Molecular mechanisms controlling 
homeostasis of self-renewing organs and 
their dysregulation during tumorigenesis” [35] 
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In endothelial cells Jagged-1 seems to play a role in contact inhibition by preventing the 
phosphorylation of the retinoblastoma protein (Rb). Rb is a tumor suppressor that inhibits cell 
cycle progression between G1- and S-phase. In the hypophosphorylated state it is active and 
inhibits transcription factors of the E2F family that cause entry into the S-phase. Rb is 
phosphorylated and thereby inactivated by cyclinD/CDK4 and cyclinE/CDK2 complexes. 
Through Jagged 1 activated Notch signaling, phosphorylation of Rb is inhibited and the cell 
cycle is arrested. These effects seem to be partly achieved by changes in the expression of 
p21. [39] 
 
 
  
Additionally, endothelial expression of JAG1 plays an important role in smooth muscle 
development. [38] 
Jagged 1 also has oncogenic properties.  It has been found to be overexpressed in patients 
suffering from acute myeloid leukemia (AML). [40] In breast cancer patients elevated levels 
of JAG1 mRNA is associated with poor diagnosis. [41]. Together, although Jag-1 has been 
described in endothelial cells, its role in the inflammatory process remains to be established. 
 
 
 
 
 
 
 
 
 
Fig.2.14.: 
Regulation of  the Rb protein 
Active Rb inhibits E2F and thereby 
inhibits cell cycle progression 
By cyclin/CdK complexes it is 
phosphorylated, the elongation 
factor is released and the cell can 
enter the S-phase. 
Graphic:”The tp53 web side” 
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2.9. TNFRSF11B 
  
TNFRSF11B encodes osteoprotegerin (OPG), a protein essential for bone homeostasis. 
Bone is constantly remodelled by osteoclasts that have degrading functions and osteoblasts 
synthesizing new material. This balance between resorption and bone formation is partly 
regulated by the RANK/RANKL/OPG system. The cytokine RANKL (receptor activator of 
nuclear factor NF-κB ligand) belongs to the family of tumor necrosis factors (TNFs) and is 
expressed on osteoblasts and bone marrow cells. Binding of RANKL to its transmembrane 
receptor RANK stimulates bone resorption by two different mechanisms: On the one hand it 
induces the differentiation of precursor cells to osteoclasts, on the other it activates mature 
osteoclasts. The soluble protein osteoprotegerin is the second receptor for RANKL. Binding 
of RANKL to OPG prevents RANK/RANKL interactions and therefore inhibits bone 
resorption. Thus, OPG acts as decoy receptor [42]. 
 
 
 
An imbalance of the RANK/RANKL/OPG system is involved in the pathogenesis of various 
diseases concerning the skeleton like postmenopausal or glucocorticoid-induced 
osteoporosis and rheumatoid arthritis. Further, the system plays a role in oncologic 
processes like the progression of multiple myelomas. This plasma cell cancer is associated 
with bone loss caused by enhanced osteoclastogenesis. Other cancer types (e.g. breast and 
prostate carcinoms) do not develop in the bone, but have a strong affinity to develop skeletal 
metastases. As prerequisite for colonization of the bone, osteolysis must occur. Beside to the 
capacity of tumor cells to develop an osteoclast phenotype, degradation of the bone is 
caused by changes in the RANK/RANKL/OPG system of osteoclasts.  
Juvenile Paget´s disease (JPD) is an autosomal recessive disorder that can be caused by 
mutations in the TNFRSF11B gene. The phenotypic effects are versatile and include skeletal 
Fig.2.15: 
The RANK/RANKL/OPG system 
OPG acts as decoy receptor by preventing RANK/RANKL 
interactions 
Grafic: “The osteoprotegerin/RANK/RANKL axis of bone 
formation regulation.” 
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and dental abnormalities, fractures and hearing deficits. JPD is caused by different kinds of 
mutation, whereby all of them affect the ligand-binding properties of OPG. [43] 
The RANK/RANKL/OPG system seems also to play a role in vascular calcification 
associated with arteriosclerosis and osteoporosis. The observation that OPG-/- mice develop 
arterial calcification and aneurysms in the large arteries support the hypothesis that it is 
involved in the vascular pathophysiology.  
RANK is expressed in endothelial cells of the vasculature and is activated by RANKL 
expressed in smooth muscle cells in a paracrine manner. These interactions cause activation 
of the Pl3´-kinase/ Akt pathway and provide endothelial cell integrity by regulating cell 
survival. Upon TNF-α stimulation OPG is up-regulated and inhibits RANK/RANKL signalling 
and consequently the survival pathway. Thus, OPG is eventually contributing to the TNF-α 
induced endothelial damage [59]. 
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2.10. TNFSF15 
 
TNFSF15 encodes a member of the TNF family, vascular endothelial growth factor (VEGI) 
and shows 20-30% homology to other members of the superfamily. VEGI is expressed in 
many different tissues including lung, kidney, placenta, small intestine and colon, spleen, 
pancreas and prostate. The highest levels of TNFSF15 expression have been observed in 
vascular endothelial cells. In the endothelium VEGI specifically acts as strong growth 
inhibitor, whereby its effect is dependent on the cell stage. In G0-G1 endothelial cells VEGI 
induces growth arrest, in proliferating cells it causes apoptosis. As a result, it has been 
shown to act as a potent inhibitor of angiogenesis. The vascular homeostasis provided by 
VEGI is essential for the maintenance of vascular integrity (hairy/enhancer split) and HRT 
(hairy-related transcription factor) [45, 46]. 
The previously described VEGI protein is one of three different splicing forms of VEGI called 
VEGI-174. This 174 amino acids containing gene product is a type II membrane bound 
protein. Two other splicing variants are known: VEGI-192 and VEGI-251. The soluble VEGI-
251 protein is also termed TL1A and is involved in the reaction of the organism to 
inflammation. It acts as ligand for DR3, a receptor up-regulated during T-cell activation. Upon 
binding activating and proliferative signals are induced, mainly by activation of NF-κB. 
Because the secretion of INF-γ is induced by TL1A, it is thought that it directs the immune 
answer towards a TH1-mediated response [47]. Recent data revealed that DR3 is also 
expressed on NK cells, macrophages and endothelial cells, whereby the effect of receptor 
activation is not known in theses cell types [48]. The interactions between TL1A and DR3 
can be inhibited by when TL1A binds the decoy receptor DcR3. Imbalances in this system 
might be involved in the pathogenesis of rheumatoid arthritis [49]. 
The capacity of TL1A to act as TH1-polarizing cytokine is also the background of its role in 
the pathogenesis of the inflammatory bowel disease (IBD). TNFRSF15 expression is 
significantly up-regulated in macrophages and lymphocytes of patients suffering from the 
major forms Crohn´s disease (CD) and ulcerative colitis (UC) [50]. 
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2.11. Principle of Reporter gene assays 
 
Generally, a reporter gene encodes a protein that can be easily identified and quantified. 
Fused to appropriate regulatory elements it can be used to analyze the activity of 
transcription factors or promoter regions of certain genes. 
Two different systems are available for these purposes: The cis-system consists of one 
plasmid carrying a luciferase gene under the control of a minimal promoter and a variable 
enhancer element. When the transcription factor of interest is activated, it binds to its specific 
enhancer element and activates the expression of luciferase. In the case of the NF-κB 
reporter system the luciferase gene is under the control of an artificial promoter containing 
five κB binding sides. For the examination of the promoter region of e.g. IL-8, a more natural 
promoter is used. This element is – like in vivo - activated by a combination of different 
transcription factors (NF-κB and AP-1). 
The trans-system is composed of two plasmids. The transactivator plasmid expresses a 
fusion protein consisting of the DNA binding domain of GAL4 and the transactivation domain 
of a transcription factor of interest. The reporter plasmid carries the reporter gene under the 
control of a minimal promoter and a multimerized GAL4 binding side. If the transactivator 
protein is activated e.g. by phosphorylation, the fusion protein can induce the expression of 
luciferase. This system allows the observation of specific signalling pathways. 
 
 
 
 
 Fig.2.15.:
Scheme of Reporter constructs, cis-system  
The luciferase gene is under the control of a minimal 
promoter and an enhancer element specific for a particular 
transcription factor 
Fig.2.16.: 
Scheme of Reporter constructs, trans-system  
The luciferase gene is under the control of a minimal 
promoter and fused to a GAL4 binding side. 
The fusion protein expressed on another plasmid binds the 
GAL4 binding side via its GAL4 DNA binding domain. 
Prerequisite for binding and luciferase expression is the 
activation of the transactivator protein 
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In both cases the expression of the reporter gene is dependent on the transcription factors of 
interest. Thus, proportional to its increasing/decreasing activity the measurable expression of 
luciferase increases/decreases. 
To eliminate experimental variabilities e.g. variations in transfection efficiency, a second 
reporter gene (β-galactosidase or Renilla luciferase) is co-transfected as internal control and 
used for normalization. To keep the total amount of transfected DNA constant when 
combining different plasmids, an empty vector is used.  
 
Material and Methods 
25 
 
3. Material and Methods 
 
3.1.  DNA Methods: 
 
3.1.1. Restriction Digest: 
 
For restriction analysis of DNA the “Roche Buffer System” was used according to the 
manufacturer`s instructions. Control digests of plasmids to confirm their integrity were done 
in a final volume of 20μl. For the cloning of the constructs higher amounts of DNA were 
digested, therefore the reaction was performed in 50μl. All approaches were incubated at 
least for 1 hour at 37°C. For double digestions, enzymes were chosen that work in the same 
buffer as far as possible. When this was impractical the DNA was digested by the first 
enzyme for 1 hour at 37°C in the half of the final volume. Subsequently the second half of the 
digestion mix containing the second enzyme and its appropriate buffer was added and the 
incubation repeated. The first digest was always performed using the enzyme with the lower 
salt requirement.  The samples were analyzed on agarose gels of different concentrations 
according to the size of the expected fragments. As control undigested/single digested 
samples were applied. 
 
Single digest / double digest with enzymes working in the same buffer: 
DNA (1μg/μl)  1μl / 3μl 
Buffer   2μl / 5μl buffer (10% of final volume) 
Enzyme (each) 0,5μl 
ddH20   to 20μl / 50μl 
 
Double digest with enzymes working in different buffers: 
DNA (1μg/μl)  1μl / 3μl                         
Buffer 1  1μl / 2,5μl buffer        
1st Enzyme  0,5μl 
ddH20   to 10μl / 25μl 
 
Buffer 2  1μl / 2,5μl buffer        
2nd Enzyme  0,5μl 
ddH20 to   10μl / 25μl 
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3.1.2. Re-Transformation: 
 
Chemical competent cells were thawed on ice and 150μl of the suspension united with 0.5μg 
plasmid DNA. After 20min incubation on ice the cells were exposed to a “heat shock” (1min; 
42°C), subsequently 1ml LB media was added and the cells were shaken (37°C; 30min; 
250rpm). By centrifugation (5min; 3.500rpm, RT) the cells were pelleted and the supernatant 
was discarded to a large extent. The cells were resuspended in the remaining ~100μl and 
plated on selective agar plates.    
 
3.1.3. Miniprep: 
 
Plasmids were isolated using the “Qiagen buffer system” and a modified protocol.  
Depending on the resistance provided by the respective plasmid, a single colony was 
inoculated in 3ml LB + Ampicillin (100 µg/ml) or Kanamycin (50 µg/ml) and shaken o.n. at 
37°C and 250rpm.  1.5ml of the culture were transferred in Eppendorf tubes and centrifuged 
(5min; 8000rpm; RT). The supernatant was discarded and the pelleted bacterias were 
resuspended in 250μl buffer P1 by vortexing. Lysis of the cells was achieved by addition of 
250μl buffer P2, inversion of the tubes and 5min incubation at RT. The lysate was neutralized 
by addition of 250μl buffer P3, followed by shaking of the tube. Debris was removed by a 
centrifugation step (10min; 13.000rpm; RT) and the supernatant transferred into a new 
Eppendorf tube. Precipitation of plasmid DNA was achieved by addition of 500μl Isopropanol 
followed by vortexing and incubation for 5min at RT. The DNA was harvested by 
centrifugation (20min; 13.000rpm; RT). After washing the pellet in 0.2ml 70% ethanol 
(centrifugation: 5min; 13.000rpm; RT) it was air-dried and resuspended in 50μl TE buffer. 
 
Buffer P1 (resuspension buffer) 50 mM TrisCl, pH 8.0 
10 mM EDTA 
100 μg/ml RNAse A 
 
Buffer P2 (lysis buffer)   200 mM 
1% SDS (w/v) 
Buffer P3 (neutralization buffer) 3.0 M potassium acetate, pH 5.5 
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3.1.4. Maxiprep:  
 
For the isolation of higher amounts of DNA the “Qiagen buffer” system and a modified 
protocol was used.  
A single colony was inoculated in 10ml LB+Ampicillin(100 µg/ml) or Kanamycin (50 µg/ml) 
and incubated for ~8 hours at 37°C and 250rpm. The suspension was transferred into 240ml 
of the same media and cultivated o.n. under the same conditions.  The cells were harvested 
by centrifugation (15min; 6000rpm; 4°C [Sorvall centrifuge; rotor: SLA-1500]) and 
resuspended in 10ml of buffer P1 by vortexing. Cell lysis was achived by addition of 10ml 
buffer P2, inversion of the tube and an incubation of 5min at RT. The lysate was neutralized 
by addition of 10ml buffer P3 and vigorous shaking. Debris was removed by centrifugation 
(10min; 4.000rpm; 4°C [Sorvall centrifuge; rotor: SLA-1500 or HB-4]) and the supernatant 
purified by filtering.  Endotoxin removal was achived by addition of 3ml (10vol%) ER buffer 
and 30min incubation on ice. During this time the Quiagen Tip was equilibrated with 10ml 
buffer QBT; afterwards the endotoxin-cleared supernatant was loaded onto the column and 
could enter the resin by gravity flow. After washing the column twice with 10ml buffer QC, the 
DNA was eluated with 15ml buffer QF into a corex tube. Precipitation was achived by 
addition of 10,5ml (70vol%) Isopropanol and vigorous shaking of the sealed tube. The DNA 
was harvested by centrifugation (30min; 9000rpm; 4°C [Sorvall centrifuge; rotor: SLA-1500 or 
HB-4]).  After discarding the supernatant the pellet was air-dried and resuspended in 400μl 
TE buffer. Subsequently an EtOH precipitation was performed: 40μl (10vol%) NaAc and 1ml 
(250vol%) EtOH abs. were added and the suspension was vortexed. After an incubation of 
for ~1hour at  -20°C the DNA was pellet by centrifugation (30min; 13.000rpm; 4°C), washed 
with 0,5ml 70% EtOH twice (5min; 13.000rpm;RT) and resuspended in 200μl sterile TE-
buffer. 
 
Buffer QBT (equilibration buffer)  750mM NaCl 
 50mM MOPS, pH 7.0 
 15% Isopropanol (v/v) 
 0,15% Triton X-100 (v/v) 
Buffer QC (wash buffer)   1.0 M NaCl 
 50mM MOPS, pH 7.0 
 15% Isopropanol (v/v) 
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Buffer QF (elution buffer)   1.25mM NaCl  
 50mM TrisCl, pH 8.5 
15% Isopropanol (v/v) 
 
3.1.5. Determination of DNA concentrations: 
 
For the determination of RNA or DNA concentrations, the samples were diluted 1:100 with 
H20 and their optical density measured in the spectrophotometer at 260nm. As reference H20 
was used. The concentration was calculated using the following formula: 
 
c = ( OD260 x F x D) /1000 
 
c: concentration in μg/μl 
OD260: optical density at 260nm  
F: specific factor; DNA: 50; RNA: 40 
D: dilution factor  
 
The ration 260nm/280nm is a measure for the purity of a solution. When purifying nucleic 
acids a ration of 1.8-2.0 is desired. If the ration is less than 1.7 the solution is probably 
contaminated. (e.g. with proteins). 
 
3.1.6. Agarose gel electrophoresis: 
 
To separate DNA molecules by their size, gel electrophoresis was performed. The 
concentration of the gel was chosen due to the length of the expected fragments: 
 
Gel Concentration (%)    DNA Size (kb) 
 
0.3                                   5-50 
0.6                                   1-20 
0.7                                   0.8-10 
0.9                                   0.5-7 
1.2                                   0.4-6 
1.5                                   0.2-3 
2.0                                   0.1-2  
  
The desired quantity of agarose was weighed in and 30ml (small gel) or 100ml (big gel) 
1xTAE buffer were added. The agarose solution was heated in the microwave until all 
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particles were completely dissolved. After cooling down to ~60°C ethidium bromide 
(500ng/ml) was added and the gel poured into the appropriate apparature. 
Before loading the DNA samples onto the hardened gel, they were united with a sixth of the 
final volume of 6xloading dye (FermentasTM). Depending on the length of the expected 
fragments appropriate DNA size markers (100bp DNA ladder plus/ 1kb DNA ladder plus; 
FermentasTM) were used. 
Electrophoresis was performed at 80V for small or 100V for big gels. The bands were made 
visible using a 300nm transilluminator. 
 
3.1.7. Extraction of DNA from Agarose Gel 
 
DNA was extracted from agarose gels using the “GFX PCR DNA and Gel Band Purification 
Kit” (GE Healthcare) and an optimized protocol. 
The required bands were excised with a sterile scalpel and transferred into 1.5ml Eppendorf 
tubes. The weights of the gel pieces were determined; per 1mg agarose gel 1μl capture 
buffer was added.  The tube was incubated at 60°C until the agarose was completely 
dissolved and the solution turned clear, then it was loaded onto a GFX MicroSpin column. 
After an incubation of 3min at RT, the column was centrifuged (1min; 6000rpm; RT) and the 
flow-through discarded. A wash step was performed by application of 0.5ml washing buffer 
and centrifugation (1min; 6000rpm; RT). Afterwards DNA was eluted by applying 25μl elution 
buffer, 3min incubation at RT and centrifugation (1min; 6000rpm; RT). To maximize the yield 
the elution was performed twice.  
 
3.1.8. Sequencing of DNA: 
 
To ensure that the IMAGE clones or the constructed expression vectors did not carry 
mutations, they were sent to MWG to be sequenced. As prerequisite 1μg DNA per 
sequencing reaction had to be precipitated. The required quantity of DNA solution was 
brought to a final volume of 100μl with TE buffer. 10μl (10vol%) NaAc and 70μl (70vol%) 
Isopropanol were added, the solution was vortexted and incubated for 10 min at 4°C. The 
DNA was pelleted by centrifugation (20min; 13.200rpm), washed with 200μl 70% EtOH and 
air-dried. 
The appropriate primers were chosen either by studying the vector map or the homepage of 
Image consortium. When internal primers were necessary (in one reaction only ~1kb can be 
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sequenced) they were designed using the program Primer3 and ordered at MOLBIOL or 
Invitrogen.  
The sequences were analyzed and compared with the reference sequence using the 
program DSgene.  
 
3.1.9. Cloning into expression plasmids: 
 
For further usage in reporter gene assays and other experiments, the genes of choice had to 
be cloned into mammalian expression vectors. Also genes that had been delivered in 
expression vectors were re-cloned, because no specific antibodies for the encoded proteins 
were available. To enable their detection by western blotting they were cloned into vectors 
carrying a flag tag.  
 
3.1.9.1. Design of expression primers: 
 
 
For the design of expression primers the program DSgene was used.  The reference 
sequences of the genes were downloaded from the NCBI data base.  The aim was to design 
primers that enable cloning of the complete CDS into the expression vector of choice in the 
right orientation and in frame.  Using the maps of the expression vectors restriction sides 
were chosen that cut the respective vector only once in its multiple cloning side. To ensure 
that the corresponding enzyme would not cut the gene to be cloned, a virtual restriction 
analysis was performed.  Because the insert had to ligate in a certain orientation, two 
different enzymes were chosen. GG2-1 and JAG1 were cloned into pcDNA3. The recognition 
sites of the forward primers were set directly before the start codon (ATG).  In the cases 
were the reading frame was changed by the restriction, one or two bases had to be inserted, 
whereby it was important to ensure that the encoded amino acid  would be as neutral as 
possible.  The recognition site of the second restriction enzyme was set directly after the stop 
codon.  TNFRSF11B and TNFSF15 carry a signal peptide on their 5´-terminus that could 
interfere with the tag of pcDNA3. Thus, these two genes were cloned into another expression 
construct carrying a tag localized on the 3´-terminus of the insert, pcDNA3.1/myc.HIS A. To 
ensure the expression of the inserts, a Kozak sequence cut by a restriction enzyme had to 
be incorporated into the forward primer. The reverse primer was designed like described 
before, whereby the stop-codon was left out. 
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Ideally both primers should have an annealing temperature of 52°C. This could be calculated 
using the following formula (only the annealing bases of the primers were counted):     
 
Annealing temperature = [A+T] x 2°C+ [G+C] x 4°C  
 
Primer                     Sequence                                                      Enzyme           Annealing Tm                       
exGG2-1fwd   5´- AAGCTTAATGCTCTCCGAAGCGG-3´  HindIII   52°C 
exGG2-1rev   5´-GGATCCTCATATGTTCTCTTCATCC-3´ BamHI   52°C 
exJAG1fwd   5´-AAGCTTAATGCGGTCCCCACGG-3´ HindIII   52°C 
exJag1rev   5´-GGATCCCTATACGATGTATTCCATC-3´ BamHI   52°C    
exTNFRSF11Bfw  5`-GGTACCATGAACAAGTGGCTGTGC-3` KpnI   54°C    
exTNFRSF11Brev  5`-TTCGAATAAGCAGCTTATTTTCACG-3` SfuI   54°C    
exTNFSF15fw   5`-GGTACCATGGCAGAGGAGCTGG-3` KpnI   54°C    
exTNFSF15rev   5`-TTCGAATAGCAAGAAAGCTCCAAAG-3` Sfu   5$4°C  
   
 
 
 
 
3.1.9.2. TOPO Cloning 
 
As intermediate step the genes of interest were cloned into a TOPO vector (pVP22). This 
technique is very efficient and provides the possibility to cut out the insert from the vector by 
various combinations of enzymes if required for other application at a later date. TOPO 
vectors are supplied in a linearized form, carrying a specific sequence [(C/T)CCTT-3´] and 
single 3´ thymidine overhangs on both ends. DNA Topoisomerase I is covalently attached to 
this recognition sequence. When PCR products with a single 3´deoxyadenosine on their 
ends are present, the enzyme is able to link the vector and the insert independently from the 
sequence of the PCR product.  
 
Fig. 3.1.:  
Kozak sequence  
Graphik: “Wikipedia” 
Tab.3.1.: Sequences of expression primers designed for cloning into expression constructs  
               Bold letters represent bases forming recognition sites of restriction enzymes, the underlining marks 
               bases that anneal to the template 
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4μl extracted PCR product, 0.5μl pVP22 vector and 1μl salt solution were mixed, incubated 
5min at RT and placed on ice. As control the same reaction mix was prepared using H2O 
instead of PCR product. After the ligation a transformation was performed: 100μl competent 
DH5α were added and the suspension incubated on ice for 30min, afterwards the competent 
bacterias were exposed to a “heat shock” (42°C, 1min). After addition of 1ml LB-media the 
cells were shaken (1 hour; 37°C; 250rpm) and pelleted by centrifugation (5min, 1100rcf; RT). 
The supernatant was discarded, the cells resuspended in ~100μl of the remaining media and 
plated on selective agarose plates. After an incubation of about 12 hours at 37°C various 
colonies were picked and inoculated in 3ml LB+Amp o.n. To check if a certain colony was 
carrying a TOPO vector ligated with the insert, minipreps were performed, the DNA digested 
and analyzed by electrophoresis. 
 
3.1.9.3. Polymerase chain reaction (PCR): 
 
For the amplification of the genes of interest from plasmids the Expand High Fidelity Plus PCR 
System (Roche) and a modified protocol was used.  
 
Component    Volume     Final Concentration 
5x Expand HifiPlus Reaction Buffer 10μl      1.5mM MgCl2 
PCR Grade Nucleotide Mix  1μl      200μM 
Upstream primer   1.5μl      300mM 
Downstream primer   1.5μl      300mM 
Template DNA    1.5μl      15ng   
Expand HifiPlus Enzyme Blend  0.75μl      3.75U                 
H2O     33.75μl                                                                           
Final Volume    50μl   
 
 
Fig. 3.2.:  
Principle of TOPO cloning  
PCR products with 3´deoxyadenosin ends are ligated 
with the 3´thymidine ends of the linearized TOPO 
vector. This reaction is catalyzed by Topoisomerase I.  
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                                                         Temperature                 Time                                    Cycles 
Initial Denaturation    94°C   2min    1x  
Denaturation    94°C   0.25min                                           
Annealing    52°C   0.5min    25x 
Elongation    68°C (> 3kb)   2.5min                                       
72°C (< 3kb) 
Final elongation   68°C (> 3kb)   7min    1x                               
72°C (< 3kb) 
 
The PCR products were applied onto agarose gels and the fragments required for further 
usage extracted from the gels. 
 
3.1.9.4. DNA Ligation 
 
After restricting vector and insert, both was loaded onto an agarose gel and the appropriate 
bands were extracted. To achieve a final volume of 20μl, 2μl 10xBuffer for T4 DNA Ligase 
(New England BioLabs) was diluted with 12μl H2O. In this solution 1μl vector was united with 
the 4-fold amount of insert and 1μl T4 DNA Ligase (New England BioLabs). The reaction 
mixture was incubated at 16°C o.n and 3μl used for a transformation in DH5α cells. The 
success of the procedure was checked by digesting the isolated plasmid DNA and analyzing 
the fragments on a gel.   
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3.2. Bacteriological techniques: 
 
3.2.1. Chemical competent cells: 
 
 
A single DH5α colony was inoculated in 5ml LB-media and incubated o.n at 37°C. 2ml of the 
culture was transferred into 200ml of the same media and grown until the OD600 had reached 
a value between 0.4 and 0.5. The cell suspension was centrifuged (15min; 4000rpm; 4°C) 
and the pellet resuspended in 20ml TSS buffer. After addition of 8,7ml 50% glycerol and an 
incubation of 10min on ice the cells were aliquoted (150μl) into pre-cooled tubes. After flash 
freezing the cells in liquid nitrogen they were stored at -80°C. 
 
3.2.2. Preparation of LB medium and agarose plates:  
 
For the preparation of LB medium 2.5vol% Broth Base was weighed in, dissolved in Aqua 
bidest. and autoclaved. For agar plates 1.5vol% agar was added. After the media had 
reached a temperature of 56°C the required antibiotic was added (Ampicillin:100 µg/ml; 
Kanamycin 50 µg/ml) and the plates were poured under sterile conditions. The plates were 
stored at 4°C. 
 
25g LB Broth Base (Invitrogen) 
15g Agar 
H20 to 1l 
 
3.2.3. Cultivation of Image Clones: 
 
The vectors containing the desired genes were delivered in bacterial hosts growing on agar. 
Because all of the vectors express an Ampicillin resistance gene, the colonies were plated on 
Amp-plates. After 24h of incubation one single colony from every plate was picked, 
inoculated in LB+Amp and shaken at 37°C and 250rpm o.n. 
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3.3. Cell culture 
 
3.3.1 Cultivation of HEK293  
 
 
HEK293 were grown under sterile conditions in DMEM (Dulbeccos Modified Eagle Medium; 
Gibco Invitrogen) supplemented with fetal calf serum, penicillin/streptomycin and glutamin in 
culture flasks (TC Flask 25CM2; Nunc). In the incubator a humidified atmosphere of 5% CO2 
was provided. When cells reached 80% - 90% confluence they were splitted. Usually this 
was done every 2-3 days 1:5 or 1:6.  Before passaging the cells, the layer was washed with 
3ml sterile PBS, then the cells were trypsinised (1.5ml Trypsin) and observed under the 
microscope. When most of the cells were detached, the reaction was stopped by addition of 
10ml DMEM (FCS inhibits Trypsin).The required amount of cell suspension was transferred 
into a new culture flask and DMEM was added for a final volume of 15ml.  
 
DMEM:   HyClone; DMEM/High Glucose; Cat.No. SH30022.0; Thermo Scientific 
               10% (v/v) FCS, heat inactivated; Gibco 
                Penicillin / Streptomycin (Pen: 50U/ml; Strep: 50μg/ml); BioWhittaker 
               1mM Glutamin; BioWhittaker0 
The components were united, steril filtered (0.2μm) and the medium stored on 4°C. 
 
3.3.2. Freezing of HEK293 
 
The required number of cryo-tubes was placed in a freezing pot filled with isopropanol and 
precooled at 4°C. Freezing media (90% DMEM+10% DMSO [containing 10% FCS, 
Pen/Strep and Glutamin]) was stored on ice. The cells were washed with 2.5ml sterile PBS 
and trypinised (1.5ml trypsin). The single cells were resuspended in 10ml media and 
centrifuged (3min; 1000rpm; RT), the pellet was resuspended in 3ml freezing media. 1ml 
aliquots were transferred into the cryo-tubes and stored at -80°C o.n. Subsequently the cells 
were stored in liquid nitrogen.  
 
3.3.3. Thawing of HEK293 cells 
 
The frozen cell suspension was placed in a 37°C water bath. When the media was almost 
completely thawed it was transferred into a 15ml falcon tube containing 10ml DMEM and 
centrifuged (5min; 1000rpm; RT). The supernatant was discarded carefully, the pellet was 
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resuspended in 5ml DMEM and the solution transferred into a T80 culture flask already 
containing 10ml DMEM. Before the cells were used for experiments (e.g. reporter gene 
assays) they were passaged at least twice.    
 
3.3.4. DAPI staining 
 
To test the cells for mycoplasm and other intracellular infections, DAPI staining was 
performed. DAPI stains DNA, so in an infected culture not only the chromosomal DNA of the 
cells but also the DNA of the bacterias gets visible. Four chamber slides ( Lab-Tek II 
Chamber Slide; Nalge Nunc International) were coated with 0.5ml gelatine for at least 15min. 
Afterwards different quantities of cells suspension (100μl, 200μl, 300μ, 400μl) were given into 
four chambers, brought to a final volume of 400μl with pre-warmed DMEM and incubated o.n 
at 37°C. As preparation for the staining the cells layers were washed with 100μl PBS 
complete (2x) and fixed with 150μl 4% paraformaldehyd for at least 15min at 37°C.  After two 
additional wash steps with 100μl PBS complete, the cells were incubated with 150μl DAPI 
solution (1:500 with PBS complete) for at least 15min and washed again (2x). The chamber 
was removed from the slide; rests of glue were removed using a sterile scalpel. One drop of 
mounting fluid (Geltol Mounting Medium; ImmunonTM Thermo Shandon) was applied per 
chamber and a cover glass put onto the slide. The cells were analyzed using fluorescence 
microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.3.: 
DAPI staining of an 
mycoplasma infected HEK293 
culture 
Arrows indicate mycoplasma 
DNA 
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3.3.5 Transient transfection and Reporter gene assay 
 
 
3.3.5.1 Calcium-Phosphat Transfection of HEK293: 
 
 
For introducing foreign DNA into HEK293, cells were transiently transfected using the 
calcium-phosphat method. This technique is based on the fact, that CaCl2 and HeBS 
(HEPES-buffered saline) form a fine precipitate when united under advantageous conditions.  
The positively charged calcium and the negatively charged phosphate form complexes that 
are able to bind the DNA to be transfected on their surface. When this suspension is added 
to the cells the bound DNA is able to pass the plasma membrane mediated by a process that 
is not completely understood. 
In preparation HEK293 were seeded in gelatine-coated multi-well dishes (1x106 cells per 6-
well or 0.25x106 per 24–well) approximately 16 hours before the experiment was done. When 
the transfection was performed the cells were supposed to be 50-60% confluent. For the 
transfection of one 6-well a total of 4μg DNA was united in a 1.5ml Eppendorf tube. A dilution 
of 9µl CaCl2 in 58 µl H2O was added. 71μl HeBS were added dropwise while bubbling the 
DNA solution with a Pasteur pipette on a pipette boy. After an incubation of 1 min the whole 
mixture (142μl) was applied onto the 6-well. When 24-well plates were transfected, 1/4 of the 
suspension (35,5μl) was applied per well. 
After incubation of optimally 16, but at least 4 hours, the medium was replaced. Cells were 
harvested 48 hours after transfection.   
 
2xHeBS: 280mM NaCl 
1.5mM Na2HPO4 · 7H2O 
50mM HeBS (Sigma) 
In A. bidest. ; pH 7.05 
 
CaCl2:  2M CaCl2 · 2H2O 
 
Both solutions were sterile filtered (0.2μm), aliquoted and stored at -20°C.  
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3.2.5.2. Reporter gene assay: 
 
To observe the effects of the genes of interest in HEK293, cells were transfected with a 
constant quantity of reporter constructs and increasing concentrations of the genes. In 
parallel the same experiment was performed, co-transfecting the cells with a constant 
amount of an inducer of the respective transcription factor. All experiments were performed 
in triplicates.  
 
  
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
Gene of 
interest 
 
0 
 
0.5 
 
1.0 
 
1.5 
 
0 
 
0.5 
 
1.0 
 
1.5 
 
Reporter 
plasmid 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
Normalizing 
Reporter 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
0.5 
 
Empty 
Vector 
 
3.0 
 
2.5 
 
2.0 
 
1.5 
 
2.5 
 
2.0 
 
1.5 
 
1.0 
Pathway 
specific 
inducer 
 
0 
 
0 
 
0 
 
0 
 
0.5 
 
0.5 
 
0.5 
 
 
0.5 
 
Total 
 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
4 
 
 
After 48 hours the cells were harvested and frozen at -20°C for ~1 hour to facilate the 
subsequent lysis. Lysates were produced by adding 50μl 1xPassive Lysis Buffer (Promega) 
per well and shaking for 1 hour at RT. 
For the luciferase assay 10μl of the lysates were transferred into appropriate tubes (5ml, 
75x12mm, PS; Sarstedt). Because the injection mix was added automatically (100μl per 
sample), the total prepared volume was set in the reservoir of the luminometer (Lumat LB 
9501; Berthold). To avoid contaminations from former experiments, a single wash cycle 
using this mix was performed. To each sample 350μl reaction mix was added manually right 
before measuring. In the presence of ATP and Mg+2, Luciferase catalyzes the oxidation of 
Luciferin to Oxyluciferin, resulting in bioluminescence. This light output was usually 
measured for 10 sec. 
For the β-galactosidase assay 10μl of the lysates were transferred into 96-well plates and 
incubated with 90µl CPRG reagent until a clear colour change was observable. β-
Fig. 3.4.: 
Pipetting 
scheme of a 
typical reporter 
gene assay 
performed in a 
24-well plate 
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Galactosidase catalyzes the cleavage of CPRG. The resulting product was quantified by 
spectrophotometry in an Anthos 2 plate reader at 580nm. 
For the normalization of the results, the RLUs (relative light units) from the Luciferase assay 
were divided by the β-Galactosidase values for each triplicate.  Then the average value was 
calculated for each sample. To illustrate the fold-induction/inhibition, the values of the 
samples transfected with the gene of interest, were referred to the control-sample.  
 
 Reaction mix:   25mM Glycine-Glycine, pH 7.8 
1M MgSO4   
20mM Adenosin-5´- triphosphat (ATP) 
 
Injection mix:   25mM Glycin-Glycin 
1mM Luciferine (Roche) 
 
CPRG:    0.05% (w/v) CPRG (Roche) in PBS with 0.1% (w/v) BSA 
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3.4. Protein methods 
 
3.4.1. Preparation of lysates for western blotting 
 
To avoid degradation of the proteins all steps were performed on ice. 50μl 1 x Passive lysis 
buffer were applied onto the cells. After removing the required quantities for the reporter 
gene assay, the triplicates were pooled, united with a fifth of the final volume of 5xLämmli 
buffer and boiled at 95°C for 10min. 
For testing on the expression of the genes of interest 6–wells were transfected. In these 
cases the cell layer was washed with 1ml PBS and the cells flushed from the surface and 
resupended in the same volume. The cells were pelleted (5min; 4000rpm; 4°C), resuspended 
in 100μl Laemmli buffer and boiled at 95°C. After three freeze and thaw cycles (5min, 95°C; 
freezing in liquid nitrogen) the samples were applied onto the gene. 
 
3.4.2. Sodium Dodecyl Sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE): 
 
For separating proteins according to their size SDS-PAGE was performed.  The 
concentration of the separating gel was chosen due to the size of the protein to be detected 
(see table). If this was unknown it was calculated using following formula:   
 
  1kb DNA = 333aa coding capacity = 3.7x104 (= 37 kDa) 
 
Gel Concentration (%)    Proteine Size (kDa) 
  8%          40-200kDa        
10%          21-100kDa 
12%            10-40kDa 
 
The components of the separating gel were united, poured into the appropriate apparature 
and allowed to polymerize. To ensure a flat surface and avoid air bubbles, the gel was 
overlaid with butanol, which was removed later by H20 and Whatman paper.  To create the 
slots, a comb was inserted and the stacking gel poured. After complete polymerization the 
gel was transferred into a chamber containing 1x Running buffer. The samples were applied 
using a “Hamilton needle”. 5μl of a defined protein mixture served as size marker. While the 
samples were passing the stacking gel electrophoresis was carried out at 80V, afterwards 
the gel was allowed to run at 120V. 
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Component 
(ml) 
 
5.0% 
 
7.5% 
 
10% 
 
12.5% 
 
15% 
 
20% 
 
H2O  
 
5.75 
 
4.95 
 
4.1 
 
3.3 
 
2.45 
 
0.8 
 
Solution A 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
Solution B 
 
1.7 
 
2.5 
 
3.4 
 
4.2 
 
5.0 
 
6.7 
 
10% APS (μl) 
 
50 
 
50 
 
50 
 
50 
 
50 
 
50 
 
Temed (μl) 
 
10 
 
10 
 
10 
 
10 
 
10 
 
10 
Tab.3.2: Components of separating gels of different concentration  
 
 
Component 
(ml) 
 
4% 
 
H2O 
 
3.1 
 
Solution Ast 
 
1.25 
 
Solution B  
 
0.65 
 
10% APS (μl) 
 
50 
 
Temed (μl) 
 
10 
Tab.3.2:  
Components of the stacking gel 
 
 
3.4.3. Western blotting: 
 
 
To detect the proteins of interest, western blots were performed. This technique is based on  
the principle of antigen-antibody binding. To expose the proteins for detection they are 
transferred from the polyacrylamide gel to a nitrocellulose membrane by electroblotting. The 
Solution A:                   1.5M Tris 
                                     0.4% SDS 
                                     in A.dest. 
                                     pH 8.8 
Solution B:   30% Acrylamid / bis-Acrylamid  
                                    (37.5:1; Serva)         
Solution Ast:                 0.5M Tris 
                                     0.4% SDS 
                                     in A.dest. 
                                     pH 6.8 
Temed:                         N, N, N`,N`- Tetramethylen- 
                                     ethylendiamine (Fluka) 
APS:                            10% (v/v) Ammoniumperoxydisulfate 
                                     (Sigma) in A. dest. 
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first antibody binds specifically to an epitope on the protein of interest and – as long it is used 
in appropriate concentrations- not to any other target on the membrane. The secondary 
antibody must be chosen due to the origin of the first one (e.g. mouse, goat) because it binds 
the Fc-region of the primary antibody, which is variable between different species. This 
secondary antibody is conjugated with an enzyme like HRP (horseradish peroxidase) that 
catalzyses a visible reaction and therefore enables the detection of the antigen-antibody 
complex.  
For the transfer a “blotting sandwich” was prepared: The membrane was incubated in Towbin 
buffer for at least 5min and placed onto three pieces of Whatman paper that had been 
soaked with the same buffer. The polyacrylamid gel was carefully taken out from the 
apparature, the stacking gel was removed and the separating gel laid onto the membrane. 
Finally, the “blotting sandwich” was covered with three pieces of Whatman paper soaked with 
Towbin Buffer and air bubbles were removed by rolling a glas pipette. Blotting was carried 
out at 350mA. 
To confirm that the transfer had been successful, the membrane was washed with tab water 
and stained with a Ponceau S solution. To facilitate the later analysis of the blot, the 
membrane was scanned or copied and destained with tab water.  
For avoiding non-specific bindings the membrane was blocked in 5% milk for 30min. After 
washing the membrane three times with PBS Tween for 5min, it was incubated o.n at 4°C 
with the first antibody (diluted 1:2000 in 5% milk). To remove unbound primary antibodies the 
washing step was repeated (3 x 5min in PBS Tween) and the membrane incubated with the 
second antibody (diluted 1:5000 in 1% milk) for 1 hour at RT.   For developing the blot, the 
membrane was incubated for 5min with a substrate containing luminol (SuperSignal West 
Pico Chemiluminiscent Substrate; Thermo Scientific) between two transparent foils and put 
into a film cassette. The HRP conjugated to the secondary antibody catalyzes the oxidation 
of luminol and thereby produces a chemoluminiscent signal. X-ray films (Super RX, Fuji) 
were laid onto the membrane and exposed for different durations (30sec-30min). The films 
were developed in a Curix 60 developing machine (Agfa). 
 
10 x Running Buffer:  250mM Tris-base 
2M Glycin 
1% SDS 
in A. dest. 
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10 x Towbin Buffer: 250mM Tris-base 
1.92M Glycin 
20% (v/v) Methanol 
In A. bidest., pH 8.6       
Milk:   5% skim milk powder (Merck) in A. bidest.  
0.02% NaN3        
PBS Tween:  136.89mM NaCl            
2.68mM KCl 
10mM Na2HPO4 · 7H2O 
1.76mM KH2PO4 
                                   In A. bidest. ; pH 7.4 
0.1% (v/v) Tween 
 
Primary Antibodies Species Dilution Secondary Antibodies Dilution 
α-flag antibody  mouse  1:2000  α-mouse antibody  1:5000 
α-HA antibody  rabbit  1:2000  α-rabbit antibody   1:5000 
α-TAK antibody  rabbit  1:2000  α-rabbit antibody  1:5000                                      
 
 
3.4.4. Co-Immunoprecipitation: 
 
For the examination of protein interactions, co-immunoprecipitations were performed.  For 
this purpose, HEK293 cells were transfected with an empty vector only or increasing 
concentrations of one of the genes encoding the proteins of interest.  In parallel the same 
experiment was performed, co-transfecting the cells with constant amounts of a second gene 
encoding the eventually interacting product.  To keep the total quantity of DNA constant, an 
empty vector was used. 
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Fig.3.5.:  
Pipetting scheme of a typical 
co-immunoprecipitation 
performed in a 6-well plate 
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After 48 hours the medium was removed and the plate placed on ice.  Cells were 
resuspended in 1ml cold PBS, transferred into pre-cooled Eppendorf tubes and harvested by 
centrifugation (700g; 5min; 4°C). Cells were washed in 1ml PBS (700g; 5min; 4°C) and 
lysates produced by resuspending them in 400μl Co-IP Buffer. After 30min incubation on ice 
debris was removed by centrifugation (13000rpm; 15min; 4°C). To ensure the over-
expression of both proteins, 40μl of the supernatant were separated and boiled with 10μl 
5xLaemmli at 95° for 5min (Input). For Co-Immunoprecipitation, 1μg antibody specific for one 
of the over-expressed proteins was added to the remaining supernatant. The antigen-
antibody mixture was rotated at 4°C for 30min. Before adding 30μl Agarose beads, they were 
equilibrated by washing them in Co-IP Buffer. The beads are associated with proteins that 
bind the Fc region of immunglobulins and can therefore pull out antibody-associated protein 
complexes from the solution. The choice of the appropriate bead-associated protein is 
dependent on the origin of the antibody. For the precipitation of rabbit antibodies, protein A 
beads were used.  After rotation at 4°C for at least 2 hours, the beads were pelleted by 
centrifugation (5000g; 2min; 4°C) and washed three times with Co-IP Buffer (5000g; 2min; 
4°C). 20μl 2xLaemmli was added and the protein solution boiled on 95°C for 5min. For 
detecting the proteins, Western blotting was performed with the samples of the input and the 
Co-IP. If the two overexpressed proteins are interacting, both of them have to be detectable 
in the samples of the Co-immunoprecipitation, because the whole complex is pulled out of 
the solution. Two ensure that both proteins are overexpressed, both of them have to be 
detected in the samples from the input. 
 
Co-IP Buffer: PBS + 0.5% (v/v) Triton X 
  0.3% (v/v) NP40 
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4. Aim and Strategy 
 
Aim of the project was the identification of genes involved in negative regulatory mechanisms 
of inflammation.  
“Negative feedback loops” are genes with inhibitory function that are expressed in response 
to pro-inflammatory stimulation. It has been shown by several examples (IκBα, A20) that 
proteins involved in the termination of an inflammatory reaction are expressed very early in 
the beginning of an inflammatory response. Thus, it could be supposed that among the 137 
IL-1 induced genes identified in the microarray one or more could be involved in negative 
regulatory mechanisms.  After selection of the targets of studies the strategy was as follows: 
 
- Image Clones of the genes of interest were obtained and their identity pre-tested by 
restriction digestion. To exclude mutations of the plasmids the DNA was sequenced 
and compared to the reference sequence. 
- By PCR the inserts were amplified and cloned into a TOPO vector as intermediate 
step. To exclude mutations the construct was sequenced. 
- The inserts were subcloned into a mammalian expression vector carrying a flag 
epitope.  
- The expression of the genes of interest was confirmed by transfection of HEK293 
followed by western blotting using anti-flag antibodies. 
- To study the influences of the genes of interest on different signaling pathways, a 
number of different reporter gene assays was performed (NF-κB, AP1-luc, NFAT-luc). 
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5. Results 
 
5.1. Testing of IMAGE clones:    
 
The IMAGE clones were cultivated and the plasmids isolated. For testing the identity and 
integrity of the plasmids, restriction analysis was performed. Restriction enzymes that cut 
sites flanking the genes in a most minimal distance were chosen, so the expected fragments 
were corresponding to their length.  
 
 
Gene 
Symbol 
 
GG2-1 
 
JAG1 
 
TNFSF15 
 
TNFRSF11B 
 
I.M.A.G.E. ID 
 
3965693 
 
6834418 
 
30740802 
 
6506550 
 
Geneservice 
Co-ordinate 
 
AV21-C8 
 
AV131-G11 
 
AV151-b8 
 
AV105-H5 
 
MGC ID 
 
11714 
 
76404 
 
0 
 
59365 
 
Species 
 
Mouse 
 
Mouse 
 
Mouse 
 
Mouse 
 
Vector 
 
pCMV-
SPORT6 
 
pYX-Asc 
 
pCMV-
SPORT6
 
pCMV-
SPORT6.1 
 
Collection 
 
IRAV 
 
IRAV 
 
IRAV 
 
IRAV 
GenBank 
Accession 
Number 
 
BC009090 
 
BC058675 
 
CF905061 
 
BC049782 
 
Unigene 
Cluster 
 
27740 
 
22398 
 
BC096494 
 
15383 
 
Genbank 
Definition 
TNFα-
induced 
protein 8 
Jagged-1 Tumor 
necrosis factor 
(ligand) 
superfamily 
Tumor 
necrosis 
factor 
receptor 11B 
                     
 
 
 
 
 
 
Table 5.1: IMAGE clones  
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The restriction analysis let suggest that the desired IMAGE clones had been delivered in the 
cases of JAG1, GG2-1 and TNFSF15. TNFRSF11B was not restricted as expected. To verify 
these results and exclude mutations in the genes of interest, the plasmids were sequenced.  
The coding regions of GG2-1, JAG1 and TNFSF15 were identical with the reference 
sequence.  The sequence of TNFRSF11B was different. BLAST analysis showed that the 
gene was not mutated, but that the original IMAGE clone was distinct from the reference 
sequence. Thus, working on this gene was discontinued.   
 
5.2. TOPO Cloning 
 
The genes of interest were amplified by PCR from the plasmids isolated from the IMAGE 
clones. Since the expression primers had been designed to anneal at the ends of the coding 
regions the expected products were corresponding to their lengths.  
 
 
 
 
Fig. 5.2:  
Restriction analysis of IMAGE clones 
  1000bp 
        3000bp 
Fig. 5.1: Vector maps of Image Clones and recognition sites used for restriction digest  
Lane 1: GG2-1 (1.8kb) excised from SPORT6 (4.4kb) using NotI and SalI 
Lane 2: JAG1 (5.4kb) excised from pYX-Asc (1.7kb) using EcoRI and NotI 
Lane 3: TNFSF15 (3.4kb) excised from SPORT6 (4.4kb) using NotI and SalI 
Lane 4: TNFRSF11B, uncut by XhoI and NotI 
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The bands representing the coding regions were excised, the DNA extracted and the PCR 
products ligated into pVP22 vectors. After transformation of competent DH5α, colonies 
carrying the vector were identified by cultivation on a selective plate. To exclude that the 
colonies were carrying a re-ligated vector only, several of them were grown up. The plasmids 
were isolated and restriction analysis performed. For restriction, the enzymes corresponding 
to the recognition sequences within the primers were used, so the expected fragments were 
almost identical with the lengths of the coding regions.    
 
  
 
 
 
 
 
Fig. 5.3.:  
PCR products of TNFSF15 
Coding region: 0.76kb 
1kb ladder 
 
Fig. 5.4.:  
PCR products of JAG1 
Coding region: 3.6kb 
1kb ladder 
Fig. 5.5:  
PCR products of GG2-1 
Coding region: 0.6kb 
1kb ladder 
Fig. 5.6.:  
Restriction analysis of TOPO vectors containing 
GG2-1 
The coding region (0.6kb) was excised using BamHI 
and HindIII 
1kb ladder 
Fig. 5.7.:  
Restriction analysis of TOPO vectors containing 
JAG1  
The coding region (3.5kb) was excised using BamHI 
and HindIII 
1kb ladder 
Fig. 5.8.:  
Restriction analysis of TOPO vectors containing 
TNFSF15 
The coding region (0.76kb) was excised using KpnI 
and SfuI 
1kb ladder 
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5.3. Cloning into pcDNA3 
 
Plasmid DNA of colonies carrying the pPV22 vector with the desired insert was isolated by 
performing a maxi-prep. The genes of interest were cut out of the TOPO vector using the 
restriction sites incorporated in the primers. The expression vectors pcDNA3 or pcDNA3.1-
His A were digested with the same enzymes.  
 
 
 
 
 
 
             
 
 
 
Fig. 5.12:  
Gene maps of mammalian expression vectors pcDNA3 / pcDNA3.1-HisA 
with restriction sites used for incorporating the genes of interest 
Fig. 5.9.: 
Restriction of pcDNA3 and GG2-1 for cloning 
Left: pcDNA3 (5.4kb) linearized by BamHI and HindIII 
Right: coding region of GG2-1 (0.6kb) and pVP22 
backbone 
1kb DNA ladder 
Fig. 5.10.: 
Restriction of pcDNA3 and JAG1 for cloning 
Left: pcDNA3 (5.4kb) linearized by BamHI and HindIII 
Right: coding region of JAG1 (3.5kb) and pVP22 
backbone 
1kb DNA ladder 
Fig. 5.11: 
Restriction of pcDNA3.1 His A and TNFSF15 for 
cloning 
Left: pcDNA3.1 HisA (5.5kb) linearized by SfuI and KpnI 
Right: coding region of TNFSF15 (0.76kb) ad pVP22 
backbone 
1kb DNA ladder 
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The bands were excised from the gel, the DNA extracted and vector and insert ligated. 
Positive colonies were identified with the same strategy pursued after TOPO cloning. 
 
 
 
  
 
 
 
5.4. Test on expression of constructs 
 
The constructs were transfected into HEK293 cells in different concentrations. Expression of 
the genes was demonstrated by production of cell lysates, performance of SDS PAGE and 
detection of the proteins by western blotting. Expression of GG2-1 and JAG1 could be 
confirmed. The protein encoded by TNFSF15 was not detectable. Re-cloning of the construct 
gave the same result. The reasons for the lack of expression for this protein could not be 
clarified, therefore this gene was not further examined.  
   
Fig 5.16: Western Blots detecting GG2-1 (left) and JAG1 (right) 
               
Fig. 5.13:  
Restriction analysis of pcDNA3 ligated with 
JAG1 (3.5kb) 
The insert was excised using BamHI and HindIII 
Fig. 5.14:  
Restriction analysis of pcDNA3 ligated with 
GG2-1 (0.6kb) 
The insert was excised using BamHI and HindIII 
Fig. 5.15:  
Restriction analysis of pcDNA3.1-His A ligated 
with TNFSF15 (0.76bp) 
The insert was excised using SfuI and KpnI 
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5.5. GG2-1: Reporter gene assays 
 
5.5.1. Effects of GG2-1 on NF-κB activity 
 
TNFα is a ligand for TNFR1 and TNFR2. TNFR1 is expressed in almost all tissues and 
activates NF-κB mediated by the classical and the non-canonical pathway. Upon ligand 
binding it recruits TRADD and TRAF2. TRAF2 activates RIP by ubiquitination. Consequently 
the TAK1/TAB1/TAB2 complex is activated leading to phosphorylation of the IKK complex. 
[51, 52] 
The TNFR further transmits signals to MAP3K like MEKK1, MEKK3 and ASK1. Also MEKK1 
and MEKK3 have been shown to phosphorylate the IKK complex by direct interactions. [53]  
 
 
 
GG2-1 over-expression did not show inhibitory influence on NF-κB activity in HEK293 cells 
stimulated with TNF-α. The protein rather seemed to have activating effects on the 
transcription factor. However, the effects of GG2-1 overexpression on TNF-α stimulated 
reporter gene expression were not extensive.  
Since the downstream components of the TNFR signalling pathways are also activated by 
distinct signalling cascades, the assay was repeated co-transfecting HEK293 with some of 
these proteins. 
 
 
Fig. 5.17.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of GG2-1 
Cells remained unstimulated or were 
stimulated with a constant quantity of TNF-α 
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In cells co-stimulated by TAK1/TAB1 a reduction of NFκB activity was observed with 
increasing concentrations of GG2-1. Similar results were achieved by co-stimulation with 
NIK, an inducer of the non-classical pathway of NFκB activation. However, in both cases the 
inhibition of luciferase activity was not more that 50% in response to the highest transfected 
Fig. 5.18.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of GG2-1 
NF-κB induction is achieved by co-transfection 
of constant quantities of TAB1 and TAK1 
 
Fig. 5.19.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV or increasing amounts of GG2-1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of NIK 
Fig. 5.20.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV or increasing amounts of GG2-1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of MEKK1 
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amount of GG2-1. The only significant inhibition could be observed in the cells over-
expressing MEKK1. In these assays a mean inhibition of NFκB activity to ~20% was 
achieved by smaller concentrations of GG2-1. 
To see if GG2-1 acts similarly down-stream from the MAP3K, cells were co-transfected with 
IKK2, a catalytic subunit of the IKK complex. The NFκB activity was not influenced by GG2-1 
over-expression in this approach. 
 
 
 
5.5.2. Effects of GG2-1 on AP-1 activity 
 
Like mentioned above MAP/ERK kinase kinase 1 (MEKK1) is activated via TNFR signaling. 
Consequently it can activate the MAPK kinase 7 (MKK7) that leads to activation of the MAP 
kinase JNK (c-Jun terminal kinase). JNK phosphorylates c-Jun and thereby enables the 
formation of  heterodimers with other proteins.  
MEKK1 also induces another kinase cascade. Via activation of the MAPK kinases MEK1/2 it 
leads to activation of ERK1/2 and enables subsequent phosphorylation of ELK1. In the 
phosphorylated form this transcription factor induces the expression of its target genes 
including c-Fos, another component of AP-1. [54,55] 
Because MEKK1 activates both, the ERK and the JNK pathway, it is a very strong inducer of 
AP-1. HEK293 cells were transfected with a constant quantity of a plasmid expressing the 
catalytic domain of MEKK1 and increasing concentrations of GG2-1. A concentration-
dependent decrease of AP-1-dependent reporter gene expression could be observed. 1μg 
GG2-1 caused a mean inhibition of more than 50%, with higher concentration a reduction to 
15% compared to the control sample was achieved. 
 
Fig. 5.21.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV or increasing amounts of GG2-1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of IKK2. 
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In order to detect the stimulating protein by western blotting, the experiment was repeated 
with a construct encoding the full length form of MEKK1 fused to a HA-tag. The results were 
similar. However, the inhibition of luciferase activity by increasing concentrations of GG2-1 
was significantly higher. Transfection of 0.5μg GG2-1 caused a decrease of reporter gene 
expression to 25% compared to the control sample. Higher concentrations lead to a 
reduction of 95%. 
 
 
  
 
 
 
 
 
 
Fig. 5.22.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
AP-1 induction is achieved by co-transfection 
of a constant quantity of MEKK1 
Fig. 5.23.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
AP-1 induction is achieved by co-transfection 
of a constant quantity of HA-tagged MEKK1 
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To test if GG2-1 has an effect on other MAP3K, cells were transfected with TAK1/TAB1 and 
MEKK3. TAK1 is activated by TNFR and IL1/TLR signaling. RIP1 or TRAF6 enable the 
formation of a complex of TAK1 with the adapter proteins TAB1 and TAB2. Consequently 
MEKK7 is phosphorylated and leads to activation of JNK. [57] 
GG2-1 over-expression caused a decrease of AP-1 activity in HEK293 cells transfected with 
a constant quantity of TAK1 and TAB1. This suppression was not extensive. In average the 
lowest transfected quantity of GG2-1 caused a reduction of reporter gene activity of 30%. 
Higher concentrations did not enhance this decrease significantly. 
 
 
 
MEKK3 also induces the JNK pathway via activation of MKK7. Amongst others, it is activated 
via TNFR signaling. In cells co-transfected with MEKK3 the results of the reporter gene 
assay were completely different from the approaches with the other MAP3K. The activity was 
not decreasing, but rather showing the opposite tendencies.  
 
 
 
Fig. 5.24.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
AP-1 induction is achieved by co-transfection 
of constant quantities of TAB1 and TAK1 
 
Fig. 5.25.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
AP-1 induction is achieved by co-transfection 
of a constant quantity of MEKK3 
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To study the effects of GG2-1 over-expression on the ERK pathway, the cells were 
stimulated with phorbol 12-myristate 19-acetate. PMA activates the protein kinase C (PKC) 
that activates Raf. Consequently the signaling cascade consisting of MEK1/2, ERK1/2 and 
ELK leads to expression of c-Fos [57]. In HEK293 cells, stimulated with a constant amount of 
PMA these pathway was not affected by GG2-1.  
 
 
 
5.5.3. Effects of GG2-1 on NFAT activity 
 
Activation of NFAT is achieved by various signaling pathways that cause an increase of the 
intracellular calcium levels.  For instance the activation of phospholipase C (PLK) can lead to 
the release of intracellular calcium stores. The enzyme cleaves phosphatidylinositol-4,5-
biphosphate (PIP2) to diacyl glycerol (DAG) and inositol-1,4,5,-triphosphate (IP3). The former 
one is bound to the membrane and is involved in the activation of PKC leading to induction of 
the ERK pathway as decribed in the former chapter. The latter one translocates to its specific 
receptors on the endoplasmatic reticulum (ER) resulting in the release of Ca+. The sensor 
protein calmodulin (CaM) activates the phosphatase calcineurin (CN) leading to 
dephosphorylation of NFAT. [58, 59] 
The activity of NFAT in response to increasing concentrations of GG2-1 was examined. 
Induction of NFAT-dependent luciferase expression was achieved by co-transfection of a 
constant quantity of NFAT-GFP. GG2-1 reduced the reporter gene expression in a 
concentration-dependent manner. Compared to the mock sample transfection of 0.5μg, 1μg 
or 1.5μg led to a decrease of 75%, 50% or 25%. 
 
 
Fig. 5.26.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
Cells remained unstimulated or were 
stimulated with a constant quantity of PMA. 
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5.5.4. Effects of GG2-1 on CHOP activity 
 
Another transcription factor mediating the transmission of stress signals is CHOP. It is 
induced by phosphorylation by the active MAPK p38 and acts on genes involved in cellular 
growth, differentation and inflammation. The activation of p38 is induced by environmental 
stress or pro-inflammatory cytokines. TNFR signaling activates p38 via activation of ASK 
resulting in activation of MEKK3/6. These kinases are also activated by TAB1/TAB1/TAB2 
resulting in the phosphorylation of p38.  Stress signals causing p38 activation are transmitted 
by small GTPases of the Rho family (Rho,Rac, Cdc42). [60] 
In HEK293 cells co-transfected with p38α increasing amounts of GG2-1 had no inhibitory 
effects on the activity of CHOP.  Rather it caused enhanced reporter gene expression, 
whereby this effect was not extensive. The highest transfected quantities of GG2-1 caused a 
2-fold induction compared to the control sample. 
 
 
 
Fig. 5.27.: 
Reporter gene assays in HEK293 
NFAT promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
NFAT induction is achieved by co-transfection 
of a constant quantity of NFAT-GFP 
 
Fig. 5.28.: 
Reporter gene assays in HEK293 
CHOP activity in cells transfected with EV or 
increasing amounts of GG2-1 
CHOP induction is achieved by co-transfection 
of a constant quantity of p38α 
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5.5.5. Effects of GG2-1 on p53 activity 
 
HEK293 cells co-transfected with constructs encoding the tumor suppressor p53 showed a 
concentration-dependent decrease of p53-dependent reporter gene activity. The highest 
transfected quantity of GG2-1 caused a mean suppression of reporter gene activity to 50% 
compared to the control sample.  
 
 
 
5.5.6. Effects of GG2-1 on the IL-8 promoter 
 
The pro-inflammatory cytokine IL-8 contains binding sides for NF-κB and AP-1 in its 
promoter.  
An assay using a reporter construct carrying a luciferase gene under the control of a -600 bp 
IL-8 promoter was performed. In former experiments cells co-transfected with MEKK1 
showed a decrease of NFκB and AP-1 activity in response to GG2-1. In line with these 
observations, the IL-8 promoter-dependent reporter gene expression was strongly inhibited 
by GG2-1 in cells co-transfected with the full length form of MEKK1. 
Fig. 5.29.: 
Reporter gene assays in HEK293 
tp53 activity in cells transfected with EV or 
increasing amounts of GG2-1 
tp53-dependent reporter gene expression  
induction is achieved by co-transfection of a 
constant quantity of p53 
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The same approach was performed by co-transfecting MEKK3. In the AP-1 reporter gene 
assay GG2-1 showed an inductive effect in MEKK3 stimulated HEK293 cells. A similar 
influence was observed in the IL-8 reporter assay. On average GG2-1 caused 5-fold 
induction of reporter gene expression compared to the control sample. This effect was widely 
concentration-independent. 
 
 
 
 
TNF-α stimulation of the cells led to a similar result like on the NF-κB-reporter. No inhibitory 
effects could be observed. In contrast, GG2-1 over-expression seemed to have an 
enhancing effect on reporter genes expression. However, this effect was not very 
pronounced, the maximal induction was 2-fold in average. 
 
 
 
 
 
 
 
Fig. 5.30.: 
Reporter gene assays in HEK293 
IL-8 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
IL-8 promoter activity is induced by co-
transfection of a constant quantity of MEKK1 
 
Fig. 5.31.: 
Reporter gene assays in HEK293 
IL-8 promoter activity in cells transfected with 
EV or increasing amounts of GG2-1 
IL-8 promoter activity is induced by co-
transfection of a constant quantity of MEKK3 
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In summary, the reporter gene assays showed, that GG2-1 has strong inhibitory effects on 
the activity of the NF-κB, AP-1 and IL-8 promoters in cells co-transfected with MEKK1. Also 
TAB/TAK and NIK induced signaling pathways were moderately suppressed by GG2-1 
overexpression as could be observed in NF-κB and/or AP-1 reporter gene assays. Pathways 
induced by components downstream from the MAP3K were hardly affected by GG2-1, as 
was shown by stimulation of the cells with PMA or co-transfection of IKK2.  Beside to the 
influence of GG2-1 on promoters containing κB or AP-1 binding sides, it also exhibited 
inhibitory effects on NFAT and p53 promoter activity, but not on CHOP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.32.: 
Reporter gene assays in HEK293 
IL-8 promotor activity in cells transfected with 
EV or increasing amounts of GG2-1 
Cells remained unstimulated or were 
stimulated with a constant quantity of TNFα. 
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5.6. GG2-1:  Western Blots  
 
To prove that the observed effects were caused by over-expression of the transfected genes, 
Western blots were performed detecting the encoded proteins. 
An inhibiting influence of GG2-1 on NF-κB, AP-1 and IL-1 promoter activity had been 
observed in cells co-transfected with MEKK1. The lysates of NF-κB and AP-1 reporter gene 
assays were analyzed by Western blotting. Detection of MEKK1 via its HA-tag revealed that 
the inhibitory effect resulted from decreasing concentrations of the stimulating protein. The 
more GG2-1 was transfected into the cells, the less MEKK1 was detectable in the lysates.  
 
 
 
In contrast, the protein levels of other MAP3K like MEKK1 or TAK1 seemed to be 
independent from GG2-1 over-expression 
The lysates of cells from AP-1 or NF-κB reporter gene assay were analysed. In both cases 
the protein levels of MEKK3 or TAK1 were not altered in the presence of GG2-1. 
 
 
 
            
             
Fig. 5.34.: 
Western Blot  
Detection of MEKK3 (anti-flag-AB), GG2-1 (anti-flag-AB) and β-Actin 
(anti-β-Actin-AB) as loading control in lysates from an AP-1 reporter gene 
assay  
The concentration of MEKK3 is independent on the presence and 
concentration of GG2-1                    
 
Fig. 5.33.: 
Western Blot  
Detection of MEKK1 (anti HA-AB), GG2-1 (anti-flag-AB) and β-Actin (anti-
β-Actin-AB) as loading control in cell lysates from an AP-1reporter gene 
assay  
The 196kDa form of MEKK1 is decreasing with increasing GG2-1 levels. 
                    
Results 
62 
 
 
 
5.7.: GG2-1: Co-Immunoprecipiation 
 
In order to examine if the degrading effect of GG2-1 on MEKK1 is caused by direct 
interactions between the two proteins, co-immunoprecipitation was performed. For this 
purpose, cells were transfected without or with increasing amounts of MEKK1 in the 
presence or absence of GG2-1. 
In this experiment no direct interaction of the two proteins could be observed. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.35.: 
Western Blot  
Detection of TAK1 (anti-TAK1-AB), GG2-1 (anti-flag-AB) and β-Actin 
(anti-β-Actin-AB) as loading control in lysates from an AP-1 reporter gene 
assay  
The concentration of TAK1 is independent from the presence or 
concentration of GG2-1                    
Fig. 5.36.: 
Co-Immunoprecipitation 
GG2-1 (anti-flag-AB) and MEKK1 (anti-HA-AB) 
were detected by Western blotting 
GG2-1 was detectable in the input, but not in the 
co-immunoprecipitation 
As control, MEKK1 was detected in both, the 
input and the co- immunoprecipitation 
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5.8. JAG1: Reporter gene assays 
 
5.8.1. Effects of JAG1 on NF-κB activity 
 
Over-expression of JAG1 caused a decrease of NF-κB-dependent reporter gene activity in 
TNF-α-stimulated HEK293 cells. Transfection of lower amounts of JAG1 caused reductions 
of luciferase expression to 63% or 55% compared to the control sample. A significant effect 
was observable in the cells transfected with the highest concentration of JAG1. Reporter 
gene activity was reduced to 11%.  
 
 
 
 
To get further information, cells were co-transfected with components of pathways 
downstream from TNFR. In cells co-transfected with TAK1/TAB1 no effect of JAG1 on NF-κB 
activity was observed. Only the highest transfected concentration of JAG1 caused a 
decrease of reporter gene expression. However, the first two samples show the opposite 
tendencies and therefore it is probable that the reduction is caused by an “over-loading” of 
the system. 
 
Fig 5.37 .: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected with EV 
only or increasing concentrations of JAG1 
Cells remained unstimulated or were stimulated 
with a constant quantity of TNF-α. 
Fig 5.38.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of JAG1 
NF-κB induction is achieved by co-transfection 
of constant quantities of TAB1 and TAK1 
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Similarly to the TNF-α stimulated cell, HEK293 co-transfected with NIK1 showed a 
concentration-dependent decrease of reporter gene expression. The lower transfected 
concentrations caused a decrease of NF-κB activity of 62% or 47% compared to the control-
sample.  Higher amounts of JAG1 caused a reduction to 12%. Almost identical results were 
achieved by co-transfection of MEKK1. Compared to the control-sample the reporter gene 
expression was reduced proportional to increasing concentrations of JAG1 to 60%, 52% or 
13%. Transfection of the full length form of MEKK1 showed similar results. (data not shown) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5.39.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of JAG1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of NIK1 
Fig.5.40.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of JAG1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of MEKK1 
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To get an impression of the effect of JAG1 downstream from the MAP3K, cells were co-
transfected with IKK2. In these approaches JAG1 did not show effects on NF-κB-dependent 
reporter gene expression. 
 
 
 
 
5.8.2. Effects of JAG1 on AP-1 activity 
 
HEK293 cells co-transfected with MEKK1 showed a decrease of AP-1 dependent reporter 
gene activity correlating with increasing amounts of JAG1. However, the effect was not 
extensive. The lowest transfected quantity of JAG1 did hardly inhibit luciferase expression, 
higher amounts led to a reduction to 33% compared to the control-sample.  
 
 
 
Similar results were achieved by co-transfection of TAK1/TAB1. AP-1 activity decreased with 
increasing levels of JAG1, whereby with the highest transfected quantity of JAG1 led only to 
a reduction of 50% compared with the control-sample.  
Fig.5.41.: 
Reporter gene assays in HEK293 
NF-κB promoter activity in cells transfected 
with EV only or increasing amounts of JAG1 
NF-κB induction is achieved by co-transfection 
of a constant quantity of IKK2 
Fig.5.42.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV only or increasing amounts of JAG1 
AP-1 induction is achieved by co-transfection 
of a constant quantity of HA-tagged MEKK1 
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5.8.3. Effects of JAG1 on NFAT activity 
 
Over-expression of JAG1 did not show significant effects on NFAT activity.  NFAT-dependent 
reporter gene expression was reduced to ~60% compared to the control-sample, whereby 
this effect seemed to be widely concentration-independent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5.43.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV only or increasing amounts of JAG1 
AP-1 induction is achieved by co-transfection 
of constant quantities of TAB1 and TAK1 
Fig.5.44.: 
Reporter gene assays in HEK293 
AP-1 promoter activity in cells transfected with 
EV only or increasing amounts of JAG1 
NFAT induction is achieved by co-transfection 
of a constant quantity of NFAT-GFP 
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5.8.4. Effects of JAG1 on p53 activity 
 
Reporter gene assay examining the activity of p53 revealed a significant inhibitory effect of 
JAG1 on this transcription factor. Also when low concentrations of JAG1 did not show a 
relevant influence on reporter gene expression, higher amounts led to a reduction to 11% or 
2% compared to the control sample. 
 
 
 
5.8.5. Effects of JAG1 on the IL-8 promoter 
 
The results of the NF-κB and AP-1 reporter gene assays were confirmed examining the IL-8 
promoter. Accordingly to the former experiments, JAG1 exhibited a moderate inhibitory effect 
on IL-8 promoter activity. Over-expression of JAG1 caused a decrease of reporter gene 
expression to 55%. This effect was widely concentration-independent. 
 
 
 
 
Fig.5.45.: 
Reporter gene assays in HEK293 
AP-1 promotor activity in cells transfected with 
EV only or increasing amounts of JAG1 
tp53-dependent reporter gene expression  
induction is achieved by co-transfection of a 
constant quantity of p53 
Fig.5.46 .: 
Reporter gene assays in HEK293 
IL-8 promotor activity in cells transfected with 
EV only or increasing concentrations of JAG1 
IL-8 promotor activity is induced by co-
transfection of a constant quantity of MEKK1 
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In summary, the reporter gene assays let suggest that Jagged-1 has inhibitory effects on 
some of the NF-κB inducing pathways. In cells stimulated by TNF-α or co-transfected with 
NIK or MEKK1, reporter gene expression was reduced. In contrast, when NF-κB was 
activated by co-transfection of TAB/TAK or IKK-β, JAG1 over-expression did not seem to 
have inhibitory influences. Beside to the suppressive effect of Jagged-1 on NF-κB it also 
seemed to have inhibitory influences on AP-1, NFAT and the IL-8 promoter. However, these 
effects were not extensive. The by far strongest influence of Jagged-1 was observed in the 
p53-reporter gene assays.  
 
5.9. JAG1:  Western Blots 
 
Western blotting revealed that - in contrast to GG2-1 - JAG1 had no influence on the protein 
level of MEKK1.  
 
Also the levels of other MAP3K like TAK1 were constant in all samples. 
     
 
 
Fig. 5.47.: 
Western Blot  
Detection of MEKK1 (anti-HA-AB), JAG1 (anti-flag-AB) and β-Actin (anti-
β-Actin-AB) as loading control in lysates from an AP-1reporter gene assay 
The concentration of MEKK1 is independent from the presence or 
concentration of JAG1                    
 
 
Fig. 5.48.: 
Western Blot  
Detection of TAK1 (anti-TAK-AB), JAG1 (anti-flag-AB) and β-Actin (anti-β-
Actin-AB) as loading control in lysates from an AP-1reporter gene assay  
The concentration of TAK1 is independent from the presence or 
concentration of JAG1                    
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6. Discussion  
 
The performed reporter gene assays revealed a significant inhibitory effect of GG2-1 on both, 
AP-1 and NF-κB when their induction was achieved by MEKK1. Accordingly, reporter gene 
expression regulated by the -600 bp IL-8 promoter was decreased in cells co-transfected 
with MEKK1. Western blotting revealed that this effect is caused by a decrease of the 
196kDa form of MEKK1 proportionally to increasing GG2-1 levels. Further it was 
demonstrated that this influence of GG2-1 was restricted to this respective MAP3K. The 
protein levels of TAK1 and MEKK3 were constant in all samples, independently from the 
presence or concentration of GG2-1. 
The 196kDa form of MEKK1 activates the ERK and the JNK pathway and thereby induces 
AP-1. By direct phosphorylation of the IKK complex it activates NF-κB. Besides these 
functions MEKK1 can also play a role in apotosis. Stress signals activate caspase-3 which 
cleaves MEKK1. The resulting 91kDa kinase domain fragment translocates to the 
cytoplasma and activates further caspases. Unfortunately, it was not possible to examine if 
the observed effect of GG2-1 on MEKK1 leads to formation of this respective fragment.  
Upon cleavage of MEKK1 the N-terminal domain is released. Since the HA-tag of the used 
construct was placed on the C-terminus and no 91kDa-fragment-specific antibody was 
available, detection of the pro-apoptotic form was not possible. 
 In other cell lines (e.g. human fibrosarcoma cell line HT1080) GG2-1 has been shown to 
have anti-apoptotic properties and inhibit caspase-8. Although GG2-1 does not prevent the 
proteolytic cleavage activating caspase-8, it suppresses downstream events like the 
activation of caspaspe-3 and the cleavage of Bid. [61] MEKK1 is cleaved to its pro-apototic 
91kDa form by caspase-3 [62]. Neglecting the possibility that GG2-1 shows contrary 
functions in HEK293 cells, it is therefore rather probable that it does no induce the cleavage 
of MEKK1 to a pro-apoptotic form. During the course of the experiments there was also no 
increase of apoptotic cells correlating with increasing GG2-1 levels observed. Eventually the 
decreasing 196kDa MEKK1 protein levels are not caused by cleavage to a specific fragment, 
but GG2-1 may have a degrading effect on MEKK1. The hypothesis that GG2-1 and MEKK1 
could directly interact was excluded by Co-immunopreciptation. However, there still remains 
the possibility that GG2-1 causes the decreasing MEKK1 concentrations on the protein level 
by indirect mechanisms.  Another explanation would be that GG2-1 has an influence on the 
stability of MEKK1 mRNA. The results of the reporter gene assays showed remarkable 
differences between HEK293 cells stimulated with full length form and the truncated form of 
MEKK1. Since the truncated form contains the catalytic subunit only, it can be suggested that 
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additional domains of the protein are involved in the decrease of the full length form of 
MEKK1. 
Apart from the significant reduction of activity in MEKK1 stimulated cells, moderate inhibitory 
effects of GG2-1 on NF-κB could also be observed in other reporter gene assays. In the cells 
stimulated with TAK1/TAB1 reporter gene activity was reduced to ~60%. In contrast to 
MEKK1 the protein levels of TAK1 were not affected by co-transfection of GG2-1. In two 
independent experiments it was observed that co-transfection of TAK1 only did not induce 
AP-1 activity (data not shown). This allows the suggestion that complex formation of at least 
TAK1 and TAB1 is essential for NF-κB induction in HEK293. Maybe the decreasing effects 
on NF-κB activity are caused by suppression of this dimerization by GG2-1 over-expression.  
This speculation was supported by AP-1 reporter gene assays that show very similar results 
in TAK1/TAB1 stimulated cells. Also when TAK1/TAB1 causes different degrees of induction 
in the AP-1 and the NF-κB reporter genes assays, the decrease of activity related to the 
control samples were almost identical and the TAK1 protein level constant. Because the 
inhibitory effect was in both cases not very strong, it is doubtful if it is specific and plays are 
role in vivo. 
Also HEK293 cells stimulated with NIK, another MAP3K showed a moderate decrease of NF-
κB activity. Inhibiting functions of GG2-1 downstream from the IKK complex could be 
excluded. Thus, GG2-1 overexpression in HEK293 cells seems to have inhibiting influences 
on NF-κB activity on the level of the MAP3K.   
 
          
  
 
 
Pic.6.1:  
Schematic illustration of the examined 
NF-κB activating pathways 
Pic.6.2:  
Schematic illustration of the examined 
AP-1 activating pathways 
Discussion 
71 
 
AP-1 reporter gene assays supported the impression that GG2-1 acts very far upstream in 
the signalling cascades. In these approaches the cells were stimulated with PMA that 
activates PKC. Consequently the Ras signalling cascade leads to induction of the ERK 
pathway. Since c-Fos induction was not affected by GG2-1 over-expression it can be 
suggested that GG2-1 does not exhibit inhibitory effects on the ERK pathway downstream 
from the MAP3K level.   Activation of c-Jun, the second component of AP-1 was induced by 
another MAP3K, MEKK3. In these experiments no decrease of AP-1 regulated reporter gene 
activity was observed. In contrast, GG2-1 showed an inducing effect on reporter gene 
expression, whereby these effects were not extensive. In summery the results of the AP-1 
reporter gene assays implicate that GG2-1 inhibits the activation of this transcription factor 
via inhibition of the MEKK1 mediated pathway. 
The results of the NF-κB and AP-1 reporter gene assays were confirmed by experiments 
examining the IL-8 promoter. Probably due to the presence of binding sides for AP-1 and for 
NF-κB, over-expression of GG2-1 in cells co-transfected with MEKK1 caused a significant 
decrease of reporter gene expression. Similarly to the results of the AP-1 reporter gene 
assay, GG2-1 exhibited an enhancing effect on IL-8 promoter activity in MEKK3 stimulated 
cells. IL-8 regulated reporter gene expression in TNF-α stimulated cells was not significantly 
effected by GG2-1. MEKK1 and MEKK3 are involved in signalling cascades downstream 
from the TNFR. The opposite effects of GG2-1 on pathways downstream from the TNFR 
possibly explain these results.  
GG2-1 also suppressed the activity of NFAT and CHOP, whereas it did not have effects on 
p53-regulated promoters.  
In summary the results of the reporter gene assays lead to the conclusion that GG2-1 may 
have anti-inflammatory properties. The activity of the most important inflammation initiating 
transcription factors AP-1, NF-κB and NFAT are reduced by over-expression. Additionally, 
transcription regulated by the natural IL-8 promoter is suppressed. This chemokine is one of 
the major mediators of inflammatory reactions. Amongst others it is expressed on endothelial 
cells and it induces chemotaxis in target cells like neurophiles. 
Because GG2-1 is induced by NF-κB and acts as negative regulator of pro-inflammatory 
molecules it can be regarded as a negative feedback loop. 
 
The results of the reporter gene assays implicate that Jagged-1 has inhibitory functions on 
NF-κB activation induced by TNFR signalling. Cells stimulated with TNF-α showed a Jagged-
1 concentration-dependent decrease of reporter gene activity. Examination of downstream 
components of TNFR-induced pathways gave more information about the background of this 
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effect.  In both, cells co-transfected with NIK and MEKK1, similar effects were observed like 
in TNF-α stimulated cells. Thus, it can be suggested that Jagged-1 has inhibitory functions 
on the classical and the non-classical pathway of NF-κB activation.  The inhibitory function of 
Jagged-1 does not affect all pathways induced by MAP3K. In cells stimulated with 
TAK1/TAB1 over-expression of JAG1 did not show suppressive effects on NF-κB activity. 
Also in HEK293 cells co-transfected with IKKβ reporter gene expression was not inhibited by 
JAG1 over-expression. These results allow the suggestion that Jagged-1 affects NF-κB 
activation upstream from the IKK complex. 
Jagged-1 exhibited also inhibitory effects on other transcription factors. However, these 
effects were less significant. AP-1 activity was only remarkably inhibited by high 
concentrations of Jagged-1 in all approaches. In contrast to the NF-κB reporter gene assays, 
Jagged-1 showed an inhibiting effect on luciferase expression in TAK1/TAB1 stimulated 
cells. This observation may suggest that the signalling pathway leading to MKK7 activation is 
moderately inhibited by Jagged-1, whereas IKK phosphorylation is not. NFAT activity was in 
average reduced to 65% and the suppression did not rise with increasing concentrations of 
Jagged-1. Examination of the influence of Jagged-1 on the natural IL-8 promoter confirmed 
the observation that it has inhibitory effects on pro-inflammatory processes. However, also in 
these experiments the suppression of luciferase expression was not very pronounced. In 
summary, it remains doubtful if JAG1 plays a relevant role in the resolution of the 
inflammation in vivo. 
A significant inhibitory effect of Jagged-1 was observed in p53-reporter gene assays. These 
results support the hypothesis that this protein has oncogenic properties.  By suppression of 
p53, cell cycle check points are abrogated which can lead to amplification of damaged DNA 
and loss of repair mechanisms. Noseda, Chang et al. postulated in 2004 that Jagged-1 plays 
a role in contact inhibition of endothelial cells by inhibiting the phosphorylation of the 
retinoblastoma protein (Rb). Notch activated by Jagged-1 suppresses the up-regulation of 
p21. Consequently cyclinD-cdK4-kinase activity is both, delayed and reduced and the 
release of E2F is inhibited.[39] Since p21 is a target gene of p53, the observation that p53 
activity is inhibited by Jagged-1 overexpression is according to this hypothesis. 
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Zusammenfassung: 
 
Entzündung ist im Prinzip eine schützende Reaktion des Organismus auf verschiedenste 
schädigende  Reize. Kommt es aber zu einer übertriebenen oder ständigen 
Entzündungsreaktion, so werden durch den ursprünglich nutzbringenden 
Abwehrmechanismus Schädigungen verursacht. Chronische Entzündungen sind in die 
Pathogenese von vielen unterschiedlichen  Erkrankungen  involviert. Die Aufklärung von 
Mechanismen, die die adäquate Beendigung dieser Reaktion ermöglichen ist daher ein 
wichtiges Ziel der Entzündungsforschung.  
Neben verschiedenen Immunzellen tragen auch endotheliale Zellen aktiv zu einer 
Entzündung bei. Das Endothelium kleidet die Vaskulatur aus und bildet unter normalen 
Bedingungen eine anti-koagulante Oberfläche und eine Barriere zwischen dem Blutstrom 
und dem umliegenden Gewebe. Als Reaktion auf pro-inflammatorische Stimulation kommt es 
zu phenotypischen Veränderungen der endothelialen Zellen, die es den Immunzellen 
erlauben diese Schranke zu passieren und ins Gewebe einzuwandern. Auf molekularer 
Ebene sind diese Prozesse hauptsächlich durch verschiedene induzierbare 
Transkriptionsfaktoren (e.g. NF-κB, AP-1, NFAT) reguliert. Ihre Aktivierung führt nicht nur zur 
Expression einer Vielzahl von pro-inflammatorischen Genen, sondern auch von solchen, die 
in einem späteren Stadium einer Entzündungsreaktion deren Ende induzieren. Die Proteine, 
die von solchen Genen codiert werden, formen so genannte „negative feedback loops“. Um 
neue „negative feedback loops“ zu identifizieren wurden Gene selektiert, die in 
Endothelzellen aus der humane Nabelschnur (HUVECs) durch das pro-inflammatorische 
Cytokin IL-1 induziert werden und inhibitorisches Potential aufweisen. Im Rahmen dieser 
Diplomarbeit wurden einige diese Kandidatengene in passende Expressionsvektoren kloniert 
und ihr Einfluss auf Transkriptionsfaktoren und Signaltransduktionswege die bei der 
Entzündung eine wichtige Rolle spielen, mittels Reportergen Assays analysiert. 
Eines der untersuchten Gene, GG2-1, kodiert ein FLICE–inhibierendes, anti-apoptotisches 
Protein mit onkogenem Potential. Reportergen Assays in HEK293 zeigten, dass 
Überexpression von GG2-1 einen signifikanten inhibitorischen Effekt auf die Aktivität von NF-
κB und AP-1 hat, wenn deren Aktivierung durch Transfektion der MAP3 Kinase MEKK1 
erreicht wurde. Damit übereinstimmend wurde beobachtet, dass die MEKK1-induzierte 
Aktivität des IL-8-Promoters ebenfalls proportional zu steigenden Mengen von GG2-1 sinkt. 
Detektierung des Proteins mittels „Western Blotting“ zeigte, dass die Inhibierung der 
Reportergen Expression mit abnehmenden Proteinmengen von MEKK1 assoziiert ist. Die 
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Konzentrationen von anderen MAP3 Kinasen wurde durch die Anwesenheit von GG2-1 nicht 
beeinflusst, was die Vermutung erlaubt, dass der beobachtete Effekt spezifisch für MEKK1 
ist. Durch Co-Immunopräzipitaton wurde eine direkte Interaktion zwischen den beiden 
Proteinen ausgeschlossen. 
JAG1 kodiert Jagged-1, einen der vier Liganden von Notch 1.  Aktives Notch setzt  
Signalkaskaden in Gang, die essentiell für die Zell-Zell Kommunikation sowie diverse 
Entwicklungsprozesse sind. Mutationen in JAG1 verursachen das Alagille Syndrom (AGS), 
eine autosomal dominate Erbkrankheit, die Auswirkungen auf verschiedenste Bereiche des 
Organismus hat. In endothelialen Zellen ist Jagged-1 in die Kontaktinhibierung involviert, 
wahrscheinlich durch Regulierung des Retinoblastoma Proteins (Rb). In anderen Zelltypen 
zeigt Jagged-1 onkogene Eigenschaften. Die durchgeführten Reportergen Assays zeigten 
keinen signifikanten inhibitorischen Effekt von Jagged-1 auf pro-inflammatorische wirkende 
Transkriptionsfaktoren. Im  Gegensatz dazu wurde die Aktivität des Tumorsuppressors p53 
stark unterdrückt, was vermuten lässt, dass Jagged-1 auch in endothelialen Zellen einen 
Einfluss auf onkogene Prozesse haben könnte. 
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